| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.64 | 0.002 | 0.762 | GABA aminotransferase inhibitor | 0.208 0.004 DB09269 0.238 0.004 DB04325 0.762 0.002 DBMET01955 0.246 0.004 DBMET01954 | DBMET01955 | |
| 0.568 | 0.005 | 0.697 | Peroxidase inhibitor | 0.525 0.008 DB09269 0.437 0.016 DB04325 0.697 0.003 DBMET01955 0.63 0.004 DBMET01954 | DBMET01955 | |
| 0.509 | 0.002 | 0.509 | Maillard reaction inhibitor | 0.097 0.018 DB09269 0.064 0.032 DB04325 0.407 0.002 DBMET01955 0.115 0.012 DBMET01954 | ||
| 0.523 | 0.024 | 0.847 | 5 Hydroxytryptamine release stimulant | 0.612 0.013 DB09269 0.847 0.003 DB04325 0.526 0.023 DBMET01955 0.618 0.013 DBMET01954 | DB04325 | |
| 0.499 | 0.033 | 0.753 | Aldehyde oxidase inhibitor | 0.668 0.011 DB09269 0.48 0.036 DB04325 0.664 0.011 DBMET01955 0.753 0.005 DBMET01954 | DBMET01954 | |
| 0.434 | 0.007 | 0.528 | MAO A inhibitor | 0.1 0.064 DB04325 0.528 0.005 DBMET01955 | DBMET01955 | |
| 0.421 | 0.002 | 0.421 | Diamine oxidase inhibitor | 0.04 0.023 DB09269 0.222 0.003 DB04325 0.242 0.002 DBMET01955 | ||
| 0.423 | 0.01 | 0.53 | MAO inhibitor | 0.216 0.036 DB04325 0.53 0.006 DBMET01955 | DBMET01955 | |
| 0.4 | 0.004 | 0.817 | Alcohol oxidase inhibitor | 0.594 0.003 DB09269 0.283 0.005 DB04325 0.803 0.003 DBMET01955 0.817 0.003 DBMET01954 | DBMET01954 | |
| 0.413 | 0.025 | 0.508 | Hypoglycemic | 0.477 0.017 DB09269 0.161 0.16 DB04325 0.464 0.019 DBMET01955 0.508 0.014 DBMET01954 | DBMET01954 | |
| 0.44 | 0.055 | 0.565 | Transcription factor NF kappa B inhibitor | 0.412 0.061 DB09269 0.332 0.082 DB04325 0.565 0.036 DBMET01955 0.507 0.043 DBMET01954 | DBMET01955 | |
| 0.469 | 0.085 | 0.469 | Transcription factor inhibitor | 0.448 0.092 DBMET01955 | ||
| 0.392 | 0.016 | 0.532 | 5 Hydroxytryptamine uptake stimulant | 0.514 0.004 DB09269 0.532 0.004 DB04325 0.381 0.018 DBMET01955 0.509 0.004 DBMET01954 | DB04325 | |
| 0.425 | 0.064 | 0.566 | 15-Lipoxygenase inhibitor | 0.291 0.138 DB09269 0.333 0.109 DB04325 0.566 0.029 DBMET01955 0.386 0.081 DBMET01954 | DBMET01955 | |
| 0.415 | 0.069 | 0.605 | 5 Hydroxytryptamine release inhibitor | 0.597 0.011 DB09269 0.516 0.027 DB04325 0.439 0.056 DBMET01955 0.605 0.01 DBMET01954 | DBMET01954 | |
| 0.355 | 0.015 | 0.724 | Tyrosine 3 hydroxylase inhibitor | 0.598 0.003 DB09269 0.488 0.004 DB04325 0.441 0.005 DBMET01955 0.724 0.002 DBMET01954 | DBMET01954 | |
| 0.357 | 0.023 | 0.554 | Anesthetic general | 0.554 0.005 DB09269 0.375 0.02 DB04325 0.381 0.019 DBMET01955 0.552 0.005 DBMET01954 | DB09269 | |
| 0.389 | 0.066 | 0.545 | GABA C receptor rho-3 antagonist | 0.51 0.023 DB09269 0.529 0.019 DB04325 0.421 0.053 DBMET01955 0.545 0.015 DBMET01954 | DBMET01954 | |
| 0.327 | 0.006 | 0.402 | Carbonic anhydrase XV inhibitor | 0.166 0.026 DB09269 0.372 0.005 DB04325 0.402 0.004 DBMET01955 0.22 0.016 DBMET01954 | DBMET01955 | |
| 0.294 | 0.007 | 0.546 | Histidine decarboxylase inhibitor | 0.468 0.003 DB09269 0.339 0.005 DB04325 0.42 0.004 DBMET01955 0.546 0.002 DBMET01954 | DBMET01954 | |
| 0.29 | 0.004 | 0.701 | Glutamate decarboxylase inhibitor | 0.532 0.002 DB09269 0.319 0.003 DB04325 0.492 0.002 DBMET01955 0.701 0.002 DBMET01954 | DBMET01954 | |
| 0.336 | 0.054 | 0.367 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.16 0.131 DB09269 0.367 0.046 DBMET01955 0.173 0.118 DBMET01954 | DBMET01955 | |
| 0.318 | 0.038 | 0.512 | Psychostimulant | 0.338 0.034 DB09269 0.512 0.01 DB04325 0.297 0.043 DBMET01955 0.314 0.039 DBMET01954 | DB04325 | |
| 0.293 | 0.013 | 0.367 | MAO B inhibitor | 0.166 0.032 DB04325 0.367 0.009 DBMET01955 | DBMET01955 | |
| 0.252 | 0.013 | 0.715 | GABA C receptor agonist | 0.715 0.002 DB09269 0.61 0.003 DB04325 0.241 0.014 DBMET01955 0.653 0.002 DBMET01954 | DB09269 | |
| 0.25 | 0.013 | 0.25 | Cathepsin H inhibitor | 0.198 0.023 DB09269 0.212 0.019 DB04325 0.211 0.02 DBMET01955 0.171 0.033 DBMET01954 | ||
| 0.251 | 0.015 | 0.491 | Cystathionine beta-synthase inhibitor | 0.346 0.007 DB09269 0.166 0.034 DB04325 0.394 0.005 DBMET01955 0.491 0.004 DBMET01954 | DBMET01954 | |
| 0.244 | 0.019 | 0.379 | 5 Hydroxytryptamine 3E antagonist | 0.206 0.052 DB09269 0.379 0.003 DB04325 0.196 0.07 DBMET01955 0.182 0.1 DBMET01954 | DB04325 | |
| 0.283 | 0.057 | 0.56 | Superoxide dismutase inhibitor | 0.504 0.013 DB09269 0.542 0.01 DB04325 0.351 0.036 DBMET01955 0.56 0.009 DBMET01954 | DBMET01954 | |
| 0.267 | 0.051 | 0.267 | Calpain inhibitor | 0.246 0.069 DB09269 0.263 0.054 DB04325 0.245 0.069 DBMET01955 0.23 0.084 DBMET01954 | ||
| 0.212 | 0.005 | 0.392 | DOPA decarboxylase inhibitor | 0.316 0.002 DB09269 0.177 0.011 DB04325 0.292 0.003 DBMET01955 0.392 0.002 DBMET01954 | DBMET01954 | |
| 0.214 | 0.008 | 0.282 | Nitric-oxide synthase inhibitor | 0.101 0.058 DB09269 0.282 0.005 DB04325 0.166 0.017 DBMET01955 | DB04325 | |
| 0.295 | 0.096 | 0.434 | Calcium channel activator | 0.434 0.014 DB09269 0.422 0.017 DB04325 0.278 0.115 DBMET01955 0.424 0.017 DBMET01954 | DB09269 | |
| 0.273 | 0.077 | 0.392 | Insulysin inhibitor | 0.387 0.024 DB09269 0.379 0.026 DB04325 0.29 0.065 DBMET01955 0.392 0.023 DBMET01954 | DBMET01954 | |
| 0.238 | 0.042 | 0.318 | Nitric-oxide synthase stimulant | 0.277 0.018 DB09269 0.318 0.008 DB04325 0.26 0.026 DBMET01955 0.299 0.012 DBMET01954 | DB04325 | |
| 0.348 | 0.153 | 0.466 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.434 0.073 DB09269 0.466 0.051 DB04325 0.333 0.171 DBMET01954 | DB04325 | |
| 0.194 | 0.005 | 0.22 | Myeloperoxidase inhibitor | 0.081 0.065 DB09269 0.22 0.005 DB04325 0.216 0.005 DBMET01955 0.089 0.05 DBMET01954 | DB04325 | |
| 0.255 | 0.07 | 0.372 | 5 Hydroxytryptamine 1E antagonist | 0.205 0.125 DB09269 0.372 0.007 DB04325 0.246 0.079 DBMET01955 0.217 0.111 DBMET01954 | DB04325 | |
| 0.244 | 0.062 | 0.27 | Neuropeptide Y2 antagonist | 0.214 0.096 DB09269 0.27 0.038 DB04325 0.24 0.066 DBMET01955 0.214 0.097 DBMET01954 | DB04325 | |
| 0.175 | 0.003 | 0.175 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DB09269 0.136 0.004 DB04325 0.131 0.004 DBMET01955 0.072 0.055 DBMET01954 | ||
| 0.203 | 0.033 | 0.706 | Alpha-N-acetylglucosaminidase inhibitor | 0.706 0.003 DB09269 0.295 0.017 DB04325 0.178 0.041 DBMET01955 0.596 0.004 DBMET01954 | DB09269 | |
| 0.183 | 0.015 | 0.284 | Carbonic anhydrase VI inhibitor | 0.164 0.018 DB09269 0.271 0.007 DB04325 0.284 0.007 DBMET01955 0.234 0.01 DBMET01954 | DBMET01955 | |
| 0.222 | 0.057 | 0.338 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.305 0.022 DB09269 0.314 0.019 DB04325 0.279 0.031 DBMET01955 0.338 0.014 DBMET01954 | DBMET01954 | |
| 0.156 | 0.004 | 0.156 | Vascular adhesion protein 1 inhibitor | 0.082 0.005 DB04325 0.07 0.006 DBMET01955 | ||
| 0.267 | 0.115 | 0.449 | Vasodilator, peripheral | 0.449 0.041 DB09269 0.265 0.117 DB04325 0.276 0.11 DBMET01955 0.44 0.043 DBMET01954 | DB09269 | |
| 0.163 | 0.013 | 0.261 | Inducible nitric-oxide synthase inhibitor | 0.098 0.039 DB09269 0.261 0.005 DB04325 0.125 0.023 DBMET01955 0.083 0.057 DBMET01954 | DB04325 | |
| 0.158 | 0.013 | 0.192 | Carbonic anhydrase V inhibitor | 0.171 0.01 DB09269 0.185 0.009 DB04325 0.182 0.009 DBMET01955 0.192 0.008 DBMET01954 | DBMET01954 | |
| 0.149 | 0.009 | 0.2 | Carbonic anhydrase VB inhibitor | 0.108 0.014 DB09269 0.2 0.005 DB04325 0.178 0.006 DBMET01955 0.131 0.011 DBMET01954 | DB04325 | |
| 0.157 | 0.019 | 0.552 | Porphobilinogen synthase inhibitor | 0.512 0.003 DB09269 0.321 0.005 DB04325 0.208 0.011 DBMET01955 0.552 0.003 DBMET01954 | DBMET01954 | |
| 0.284 | 0.147 | 0.353 | Antibacterial | 0.282 0.149 DB09269 0.312 0.126 DB04325 0.353 0.1 DBMET01955 0.323 0.119 DBMET01954 | DBMET01955 | |
| 0.175 | 0.039 | 0.338 | Monophenol monooxygenase inhibitor | 0.203 0.032 DB09269 0.122 0.06 DB04325 0.338 0.014 DBMET01955 0.329 0.015 DBMET01954 | DBMET01955 | |
| 0.168 | 0.032 | 0.168 | Cyclin-dependent kinase 5 inhibitor | 0.138 0.047 DBMET01955 | ||
| 0.167 | 0.031 | 0.49 | Ferrochelatase inhibitor | 0.49 0.003 DB09269 0.347 0.005 DB04325 0.094 0.078 DBMET01955 0.365 0.004 DBMET01954 | DB09269 | |
| 0.186 | 0.051 | 0.316 | Phospholipase A2 inhibitor | 0.3 0.014 DB09269 0.199 0.043 DB04325 0.215 0.035 DBMET01955 0.316 0.011 DBMET01954 | DBMET01954 | |
| 0.145 | 0.012 | 0.173 | Carbonic anhydrase VA inhibitor | 0.157 0.009 DB09269 0.166 0.008 DB04325 0.163 0.008 DBMET01955 0.173 0.007 DBMET01954 | DBMET01954 | |
| 0.145 | 0.013 | 0.155 | Ornithine decarboxylase inhibitor | 0.14 0.014 DB09269 0.151 0.011 DB04325 0.155 0.01 DBMET01955 0.14 0.014 DBMET01954 | DBMET01955 | |
| 0.256 | 0.128 | 0.386 | Vasodilator, coronary | 0.335 0.063 DB09269 0.386 0.04 DB04325 0.264 0.121 DBMET01955 0.338 0.061 DBMET01954 | DB04325 | |
| 0.133 | 0.006 | 0.185 | Estrogen-related receptor beta agonist | 0.146 0.004 DB09269 0.137 0.005 DB04325 0.18 0.003 DBMET01955 0.185 0.003 DBMET01954 | DBMET01954 | |
| 0.166 | 0.04 | 0.267 | Adenylate cyclase stimulant | 0.216 0.008 DB09269 0.267 0.004 DB04325 0.187 0.021 DBMET01955 0.233 0.005 DBMET01954 | DB04325 | |
| 0.128 | 0.004 | 0.128 | Lysine-specific demethylase 1A inhibitor | 0.049 0.048 DB04325 0.119 0.005 DBMET01955 | ||
| 0.148 | 0.024 | 0.165 | Urease inhibitor | 0.111 0.054 DB09269 0.123 0.043 DB04325 0.165 0.017 DBMET01955 0.123 0.042 DBMET01954 | DBMET01955 | |
| 0.197 | 0.074 | 0.197 | Histone acetyltransferase inhibitor | 0.182 0.096 DB04325 0.191 0.084 DBMET01955 | ||
| 0.155 | 0.034 | 0.183 | Falcipain 3 inhibitor | 0.145 0.039 DB09269 0.183 0.023 DB04325 0.136 0.043 DBMET01955 0.133 0.046 DBMET01954 | DB04325 | |
| 0.229 | 0.116 | 0.297 | Streptokinase A inhibitor | 0.297 0.08 DBMET01955 | DBMET01955 | |
| 0.162 | 0.052 | 0.208 | Alkaline phosphatase inhibitor | 0.136 0.07 DB09269 0.208 0.03 DBMET01955 0.173 0.046 DBMET01954 | DBMET01955 | |
| 0.301 | 0.193 | 0.682 | Caspase 9 stimulant | 0.577 0.04 DB09269 0.465 0.075 DB04325 0.364 0.135 DBMET01955 0.682 0.026 DBMET01954 | DBMET01954 | |
| 0.145 | 0.038 | 0.305 | 5 Hydroxytryptamine 3A agonist | 0.097 0.079 DB09269 0.305 0.003 DB04325 0.125 0.052 DBMET01955 0.098 0.079 DBMET01954 | DB04325 | |
| 0.132 | 0.026 | 0.218 | Carbonic anhydrase XIII inhibitor | 0.136 0.025 DB09269 0.218 0.012 DB04325 0.208 0.013 DBMET01955 0.198 0.014 DBMET01954 | DB04325 | |
| 0.147 | 0.045 | 0.204 | Sphingosine 1-phosphate receptor 2 antagonist | 0.204 0.007 DB09269 0.179 0.015 DB04325 0.147 0.045 DBMET01955 0.198 0.008 DBMET01954 | DB09269 | |
| 0.238 | 0.136 | 0.524 | Antithrombotic | 0.524 0.026 DB09269 0.303 0.086 DB04325 0.261 0.118 DBMET01955 0.524 0.026 DBMET01954 | DBMET01954 | |
| 0.138 | 0.037 | 0.334 | GABA C receptor antagonist | 0.306 0.004 DB09269 0.334 0.004 DB04325 0.134 0.04 DBMET01955 0.275 0.005 DBMET01954 | DB04325 | |
| 0.118 | 0.019 | 0.5 | Phenylalanine 4-hydroxylase inhibitor | 0.404 0.003 DB09269 0.5 0.002 DB04325 0.189 0.008 DBMET01955 0.494 0.002 DBMET01954 | DB04325 | |
| 0.159 | 0.062 | 0.24 | GABA C receptor rho-2 antagonist | 0.24 0.014 DB09269 0.223 0.019 DB04325 0.152 0.071 DBMET01955 0.234 0.015 DBMET01954 | DB09269 | |
| 0.209 | 0.112 | 0.404 | Spasmolytic | 0.311 0.066 DB09269 0.404 0.039 DB04325 0.238 0.097 DBMET01955 0.325 0.061 DBMET01954 | DB04325 | |
| 0.171 | 0.079 | 0.4 | Succinate dehydrogenase inhibitor | 0.4 0.004 DB09269 0.234 0.029 DB04325 0.183 0.064 DBMET01955 0.386 0.004 DBMET01954 | DB09269 | |
| 0.126 | 0.034 | 0.223 | Prolactin inhibitor | 0.195 0.009 DB09269 0.202 0.008 DB04325 0.158 0.019 DBMET01955 0.223 0.006 DBMET01954 | DBMET01954 | |
| 0.268 | 0.177 | 0.395 | Alpha-glucosidase inhibitor | 0.395 0.117 DBMET01955 | DBMET01955 | |
| 0.182 | 0.092 | 0.283 | Pyruvate kinase inhibitor | 0.18 0.093 DB09269 0.283 0.052 DBMET01955 0.253 0.06 DBMET01954 | DBMET01955 | |
| 0.118 | 0.031 | 0.316 | Histamine N-methyltransferase inhibitor | 0.125 0.026 DB09269 0.316 0.003 DB04325 0.109 0.038 DBMET01955 0.122 0.028 DBMET01954 | DB04325 | |
| 0.144 | 0.059 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.189 0.005 DB09269 0.16 0.024 DB04325 0.143 0.061 DBMET01955 0.183 0.005 DBMET01954 | DB09269 | |
| 0.131 | 0.047 | 0.265 | Aminopeptidase B inhibitor | 0.265 0.011 DB09269 0.242 0.014 DB04325 0.13 0.047 DBMET01955 0.247 0.013 DBMET01954 | DB09269 | |
| 0.206 | 0.126 | 0.25 | Transcription factor STAT3 inhibitor | 0.199 0.134 DB09269 0.25 0.083 DB04325 0.229 0.102 DBMET01955 0.221 0.11 DBMET01954 | DB04325 | |
| 0.135 | 0.058 | 0.316 | Aldehyde dehydrogenase inhibitor | 0.252 0.018 DB09269 0.203 0.027 DB04325 0.194 0.029 DBMET01955 0.316 0.01 DBMET01954 | DBMET01954 | |
| 0.102 | 0.027 | 0.222 | Aminopeptidase I inhibitor | 0.222 0.005 DB09269 0.174 0.009 DB04325 0.097 0.03 DBMET01955 0.195 0.007 DBMET01954 | DB09269 | |
| 0.081 | 0.006 | 0.105 | Dihydropteroate synthase inhibitor | 0.055 0.014 DB09269 0.062 0.011 DB04325 0.105 0.004 DBMET01955 0.064 0.01 DBMET01954 | DBMET01955 | |
| 0.117 | 0.043 | 0.273 | GABA C receptor rho-1 antagonist | 0.273 0.004 DB09269 0.271 0.004 DB04325 0.105 0.055 DBMET01955 0.239 0.005 DBMET01954 | DB09269 | |
| 0.156 | 0.082 | 0.26 | Arachidonic acid antagonist | 0.257 0.004 DB09269 0.18 0.054 DB04325 0.173 0.061 DBMET01955 0.26 0.004 DBMET01954 | DBMET01954 | |
| 0.176 | 0.103 | 0.357 | Neurotrophic factor enhancer | 0.303 0.017 DB09269 0.242 0.043 DB04325 0.228 0.053 DBMET01955 0.357 0.008 DBMET01954 | DBMET01954 | |
| 0.086 | 0.015 | 0.116 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 DB09269 0.095 0.012 DB04325 0.116 0.008 DBMET01955 0.086 0.015 DBMET01954 | DBMET01955 | |
| 0.181 | 0.11 | 0.349 | Cyclic AMP phosphodiesterase inhibitor | 0.341 0.028 DB09269 0.171 0.121 DB04325 0.19 0.102 DBMET01955 0.349 0.026 DBMET01954 | DBMET01954 | |
| 0.08 | 0.008 | 0.08 | Factor XIIIa inhibitor | 0.05 0.016 DB04325 0.035 0.028 DBMET01955 | ||
| 0.076 | 0.005 | 0.088 | Endothelial nitric-oxide synthase inhibitor | 0.088 0.005 DB04325 0.034 0.018 DBMET01955 | DB04325 | |
| 0.077 | 0.007 | 0.233 | Dopamine D5 agonist | 0.093 0.005 DB09269 0.233 0.002 DB04325 0.129 0.003 DBMET01955 0.134 0.003 DBMET01954 | DB04325 | |
| 0.098 | 0.028 | 0.104 | Carbonic anhydrase inhibitor | 0.064 0.044 DB04325 0.104 0.026 DBMET01955 0.057 0.049 DBMET01954 | DBMET01955 | |
| 0.262 | 0.193 | 0.524 | Calcium channel L-type activator | 0.501 0.027 DB09269 0.471 0.04 DB04325 0.41 0.074 DBMET01955 0.524 0.02 DBMET01954 | DBMET01954 | |
| 0.232 | 0.163 | 0.294 | Calpain 2 inhibitor | 0.26 0.142 DB09269 0.294 0.118 DB04325 0.224 0.168 DBMET01954 | DB04325 | |
| 0.089 | 0.021 | 0.089 | Carbonic anhydrase I inhibitor | 0.065 0.031 DB04325 0.085 0.023 DBMET01955 | ||
| 0.142 | 0.078 | 0.169 | Neuropeptide Y1 antagonist | 0.169 0.04 DB04325 0.144 0.074 DBMET01955 0.124 0.114 DBMET01954 | DB04325 | |
| 0.086 | 0.024 | 0.086 | Carbonic anhydrase IX inhibitor | 0.085 0.025 DBMET01955 | ||
| 0.083 | 0.022 | 0.103 | Exportin-1 inhibitor | 0.094 0.012 DB09269 0.103 0.008 DB04325 0.077 0.029 DBMET01954 | DB04325 | |
| 0.2 | 0.14 | 0.408 | Lipoxygenase inhibitor | 0.309 0.067 DB09269 0.312 0.065 DBMET01955 0.408 0.035 DBMET01954 | DBMET01954 | |
| 0.084 | 0.024 | 0.084 | Carbonic anhydrase II inhibitor | 0.06 0.035 DB04325 0.084 0.023 DBMET01955 | ||
| 0.112 | 0.052 | 0.37 | Adenylate kinase inhibitor | 0.37 0.004 DB09269 0.193 0.016 DB04325 0.102 0.065 DBMET01955 0.327 0.005 DBMET01954 | DB09269 | |
| 0.177 | 0.117 | 0.438 | Free radical scavenger | 0.24 0.073 DB09269 0.389 0.031 DBMET01955 0.438 0.023 DBMET01954 | DBMET01954 | |
| 0.109 | 0.051 | 0.352 | Creatine kinase inhibitor | 0.244 0.006 DB09269 0.183 0.014 DB04325 0.184 0.013 DBMET01955 0.352 0.003 DBMET01954 | DBMET01954 | |
| 0.139 | 0.081 | 0.208 | Thiol protease inhibitor | 0.166 0.057 DB09269 0.208 0.037 DB04325 0.139 0.082 DBMET01954 | DB04325 | |
| 0.204 | 0.147 | 0.306 | Hypoxia-inducible factor 1 alpha inhibitor | 0.246 0.105 DB09269 0.272 0.082 DBMET01955 0.306 0.063 DBMET01954 | DBMET01954 | |
| 0.198 | 0.141 | 0.295 | Transcription factor STAT inhibitor | 0.191 0.151 DB09269 0.295 0.059 DB04325 0.223 0.109 DBMET01955 0.214 0.119 DBMET01954 | DB04325 | |
| 0.107 | 0.054 | 0.286 | UDP-glucose 4-epimerase inhibitor | 0.286 0.011 DB09269 0.156 0.027 DB04325 0.117 0.045 DBMET01955 0.279 0.011 DBMET01954 | DB09269 | |
| 0.062 | 0.011 | 0.062 | Plasmepsin II inhibitor | 0.045 0.022 DB09269 0.053 0.016 DB04325 0.053 0.016 DBMET01955 0.039 0.034 DBMET01954 | ||
| 0.074 | 0.023 | 0.123 | NMDA 2B receptor antagonist | 0.123 0.011 DBMET01955 | DBMET01955 | |
| 0.15 | 0.1 | 0.265 | Neurotensin receptor agonist | 0.235 0.024 DB09269 0.24 0.023 DB04325 0.175 0.056 DBMET01955 0.265 0.019 DBMET01954 | DBMET01954 | |
| 0.077 | 0.026 | 0.086 | Carbonic anhydrase XII inhibitor | 0.049 0.039 DB04325 0.086 0.023 DBMET01955 | DBMET01955 | |
| 0.142 | 0.094 | 0.326 | Melanin inhibitor | 0.21 0.037 DB09269 0.175 0.055 DB04325 0.196 0.042 DBMET01955 0.326 0.019 DBMET01954 | DBMET01954 | |
| 0.097 | 0.051 | 0.393 | Triose-phosphate isomerase inhibitor | 0.393 0.003 DB09269 0.169 0.015 DB04325 0.092 0.057 DBMET01955 0.327 0.004 DBMET01954 | DB09269 | |
| 0.198 | 0.152 | 0.396 | Gastrin inhibitor | 0.396 0.005 DB09269 0.275 0.053 DB04325 0.347 0.011 DBMET01954 | DB09269 | |
| 0.095 | 0.05 | 0.228 | NADH dehydrogenase inhibitor | 0.228 0.009 DB09269 0.143 0.019 DB04325 0.103 0.041 DBMET01955 0.223 0.009 DBMET01954 | DB09269 | |
| 0.062 | 0.018 | 0.09 | Carbonic anhydrase VII inhibitor | 0.059 0.02 DB04325 0.09 0.011 DBMET01955 0.049 0.029 DBMET01954 | DBMET01955 | |
| 0.061 | 0.019 | 0.076 | Carbonic anhydrase IV inhibitor | 0.049 0.025 DB09269 0.076 0.012 DB04325 0.053 0.023 DBMET01955 0.042 0.031 DBMET01954 | DB04325 | |
| 0.062 | 0.023 | 0.102 | Plasminogen activator inhibitor antagonist | 0.102 0.01 DB09269 0.076 0.016 DBMET01955 0.101 0.01 DBMET01954 | DB09269 | |
| 0.061 | 0.022 | 0.094 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 DB09269 0.094 0.004 DB04325 0.055 0.037 DBMET01955 0.065 0.016 DBMET01954 | DB04325 | |
| 0.084 | 0.045 | 0.333 | CYP2A6 inhibitor | 0.089 0.042 DB09269 0.333 0.004 DB04325 | DB04325 | |
| 0.062 | 0.024 | 0.094 | Alpha-mannosidase inhibitor | 0.094 0.007 DB09269 0.081 0.011 DB04325 0.062 0.025 DBMET01955 0.083 0.01 DBMET01954 | DB09269 | |
| 0.096 | 0.059 | 0.419 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.419 0.004 DB09269 0.209 0.014 DB04325 0.083 0.076 DBMET01955 0.347 0.005 DBMET01954 | DB09269 | |
| 0.056 | 0.021 | 0.105 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DB09269 0.105 0.004 DB04325 0.05 0.026 DBMET01955 0.071 0.012 DBMET01954 | DB04325 | |
| 0.107 | 0.072 | 0.158 | Acetylcholine release stimulant | 0.133 0.03 DB09269 0.158 0.012 DB04325 0.114 0.059 DBMET01954 | DB04325 | |
| 0.086 | 0.052 | 0.136 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 DB09269 0.097 0.034 DB04325 0.107 0.022 DBMET01955 0.136 0.008 DBMET01954 | DBMET01954 | |
| 0.097 | 0.064 | 0.197 | Sphingomyelinase inhibitor | 0.134 0.032 DB09269 0.197 0.01 DB04325 0.107 0.052 DBMET01954 | DB04325 | |
| 0.095 | 0.063 | 0.199 | Lanosterol 14 alpha demethylase inhibitor | 0.16 0.009 DB09269 0.199 0.004 DB04325 0.09 0.073 DBMET01955 0.152 0.011 DBMET01954 | DB04325 | |
| 0.093 | 0.061 | 0.269 | HIV-1 integrase (Overall Integration) inhibitor | 0.269 0.004 DB09269 0.195 0.013 DB04325 0.103 0.052 DBMET01955 0.263 0.004 DBMET01954 | DB09269 | |
| 0.044 | 0.012 | 0.044 | Peptide deformylase inhibitor | 0.028 0.023 DB09269 0.034 0.018 DB04325 0.028 0.024 DBMET01955 | ||
| 0.149 | 0.118 | 0.3 | DNA methylase inhibitor | 0.279 0.035 DB09269 0.206 0.076 DB04325 0.187 0.088 DBMET01955 0.3 0.028 DBMET01954 | DBMET01954 | |
| 0.05 | 0.021 | 0.115 | Histamine H2 receptor agonist | 0.041 0.033 DB09269 0.115 0.003 DB04325 | DB04325 | |
| 0.049 | 0.02 | 0.096 | Histamine H1 receptor agonist | 0.042 0.034 DB09269 0.096 0.003 DB04325 | DB04325 | |
| 0.042 | 0.014 | 0.066 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.066 0.005 DB09269 0.043 0.014 DB04325 0.044 0.013 DBMET01955 0.064 0.005 DBMET01954 | DB09269 | |
| 0.057 | 0.029 | 0.292 | Aconitate hydratase inhibitor | 0.292 0.002 DB09269 0.109 0.007 DB04325 0.18 0.004 DBMET01954 | DB09269 | |
| 0.065 | 0.039 | 0.091 | Calcium channel P-type blocker | 0.074 0.021 DB09269 0.091 0.008 DB04325 0.063 0.045 DBMET01954 | DB04325 | |
| 0.095 | 0.069 | 0.162 | Anabolic | 0.152 0.017 DB09269 0.123 0.037 DB04325 0.116 0.043 DBMET01955 0.162 0.012 DBMET01954 | DBMET01954 | |
| 0.05 | 0.026 | 0.088 | Mannosidase inhibitor | 0.088 0.007 DB09269 0.082 0.008 DB04325 0.049 0.026 DBMET01955 0.075 0.01 DBMET01954 | DB09269 | |
| 0.121 | 0.098 | 0.192 | Cell wall synthesis inhibitor | 0.181 0.039 DB09269 0.192 0.033 DB04325 0.137 0.078 DBMET01955 0.183 0.038 DBMET01954 | DB04325 | |
| 0.051 | 0.028 | 0.139 | Dopamine beta hydroxylase inhibitor | 0.077 0.005 DB09269 0.139 0.003 DB04325 0.06 0.015 DBMET01955 0.091 0.004 DBMET01954 | DB04325 | |
| 0.073 | 0.05 | 0.23 | Cathepsin G inhibitor | 0.23 0.014 DB09269 0.106 0.031 DB04325 0.07 0.054 DBMET01955 0.221 0.014 DBMET01954 | DB09269 | |
| 0.061 | 0.039 | 0.282 | Biliverdin reductase inhibitor | 0.282 0.004 DB09269 0.149 0.009 DB04325 0.205 0.005 DBMET01954 | DB09269 | |
| 0.045 | 0.025 | 0.165 | Kainate receptor antagonist | 0.165 0.004 DB09269 0.051 0.02 DB04325 0.038 0.03 DBMET01955 0.12 0.006 DBMET01954 | DB09269 | |
| 0.061 | 0.042 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.076 0.022 DBMET01955 0.064 0.036 DBMET01954 | DBMET01955 | |
| 0.024 | 0.006 | 0.04 | Estrogen-related receptor gamma agonist | 0.024 0.006 DB09269 0.026 0.005 DB04325 0.04 0.003 DBMET01955 0.035 0.004 DBMET01954 | DBMET01955 | |
| 0.057 | 0.038 | 0.109 | Leukotriene C antagonist | 0.108 0.004 DB09269 0.053 0.051 DB04325 0.059 0.031 DBMET01955 0.109 0.004 DBMET01954 | DBMET01954 | |
| 0.055 | 0.037 | 0.176 | Acyl-CoA dehydrogenase inhibitor | 0.176 0.007 DB09269 0.128 0.011 DB04325 0.128 0.011 DBMET01954 | DB09269 | |
| 0.137 | 0.12 | 0.295 | DNA methyltransferase I inhibitor | 0.272 0.037 DB09269 0.136 0.121 DB04325 0.173 0.084 DBMET01955 0.295 0.028 DBMET01954 | DBMET01954 | |
| 0.055 | 0.038 | 0.106 | Sphingosine kinase 2 inhibitor | 0.07 0.021 DB09269 0.106 0.006 DB04325 0.063 0.028 DBMET01955 0.073 0.02 DBMET01954 | DB04325 | |
| 0.054 | 0.039 | 0.117 | Epithelial sodium channel blocker | 0.063 0.024 DB09269 0.117 0.005 DB04325 0.051 0.047 DBMET01955 0.063 0.025 DBMET01954 | DB04325 | |
| 0.089 | 0.074 | 0.188 | Xanthine oxidase inhibitor | 0.125 0.045 DB09269 0.163 0.03 DBMET01955 0.188 0.022 DBMET01954 | DBMET01954 | |
| 0.09 | 0.075 | 0.242 | Electrolyte absorption antagonist | 0.242 0.005 DB09269 0.141 0.023 DB04325 0.181 0.011 DBMET01954 | DB09269 | |
| 0.057 | 0.043 | 0.161 | Carbonic anhydrase stimulant | 0.11 0.016 DB09269 0.161 0.01 DB04325 0.082 0.025 DBMET01954 | DB04325 | |
| 0.07 | 0.057 | 0.268 | Glutamate dehydrogenase inhibitor | 0.268 0.006 DB09269 0.177 0.012 DB04325 0.069 0.058 DBMET01955 0.22 0.009 DBMET01954 | DB09269 | |
| 0.056 | 0.043 | 0.081 | Botulinum neurotoxin type A inhibitor | 0.081 0.016 DB09269 0.075 0.02 DB04325 0.06 0.038 DBMET01955 0.08 0.017 DBMET01954 | DB09269 | |
| 0.027 | 0.014 | 0.039 | Acid ceramidase inhibitor | 0.03 0.01 DB09269 0.039 0.004 DB04325 | DB04325 | |
| 0.054 | 0.042 | 0.095 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 DB09269 0.095 0.011 DB04325 0.075 0.022 DBMET01955 0.087 0.014 DBMET01954 | DB04325 | |
| 0.061 | 0.05 | 0.097 | Protease 3C (Human rhinovirus) inhibitor | 0.091 0.02 DB09269 0.097 0.017 DB04325 0.081 0.026 DBMET01954 | DB04325 | |
| 0.082 | 0.071 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.134 0.009 DB09269 0.116 0.019 DB04325 0.079 0.078 DBMET01955 0.131 0.01 DBMET01954 | DB09269 | |
| 0.042 | 0.031 | 0.056 | Heme oxygenase inhibitor | 0.056 0.008 DB09269 0.05 0.013 DB04325 0.05 0.014 DBMET01954 | DB09269 | |
| 0.078 | 0.068 | 0.29 | NMDA receptor antagonist | 0.216 0.012 DB09269 0.238 0.01 DB04325 0.128 0.032 DBMET01955 0.29 0.007 DBMET01954 | DBMET01954 | |
| 0.041 | 0.031 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DB09269 0.059 0.008 DB04325 0.049 0.015 DBMET01955 0.08 0.004 DBMET01954 | DBMET01954 | |
| 0.02 | 0.011 | 0.027 | Antibiotic Anthracycline-like | 0.024 0.006 DB09269 0.019 0.013 DB04325 0.024 0.006 DBMET01955 0.027 0.004 DBMET01954 | DBMET01954 | |
| 0.079 | 0.069 | 0.101 | CC chemokine 5 receptor agonist | 0.091 0.034 DB09269 0.101 0.02 DB04325 0.086 0.047 DBMET01955 0.1 0.022 DBMET01954 | DB04325 | |
| 0.046 | 0.037 | 0.077 | Sigma receptor antagonist | 0.077 0.021 DB04325 | DB04325 | |
| 0.124 | 0.115 | 0.236 | Sphingosine 1-phosphate receptor 5 antagonist | 0.236 0.004 DB09269 0.183 0.022 DB04325 0.226 0.005 DBMET01954 | DB09269 | |
| 0.026 | 0.018 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 DB04325 | DB04325 | |
| 0.113 | 0.105 | 0.232 | Vanilloid 1 agonist | 0.209 0.01 DB09269 0.173 0.021 DB04325 0.129 0.069 DBMET01955 0.232 0.007 DBMET01954 | DBMET01954 | |
| 0.028 | 0.02 | 0.04 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DB09269 0.032 0.012 DB04325 0.038 0.006 DBMET01955 0.04 0.005 DBMET01954 | DBMET01954 | |
| 0.061 | 0.053 | 0.104 | Beta adrenoreceptor antagonist | 0.084 0.024 DB09269 0.104 0.015 DB04325 0.084 0.024 DBMET01955 0.104 0.015 DBMET01954 | DBMET01954 | |
| 0.074 | 0.066 | 0.128 | Glycine receptor antagonist | 0.128 0.014 DB09269 0.113 0.022 DB04325 0.102 0.031 DBMET01954 | DB09269 | |
| 0.025 | 0.018 | 0.042 | Vanilloid 2 agonist | 0.041 0.004 DB09269 0.037 0.005 DB04325 0.026 0.016 DBMET01955 0.042 0.004 DBMET01954 | DBMET01954 | |
| 0.032 | 0.025 | 0.049 | Melatonin receptor 1A agonist | 0.048 0.009 DB09269 0.049 0.008 DB04325 0.037 0.017 DBMET01954 | DB04325 | |
| 0.061 | 0.055 | 0.263 | Phosphofructokinase-1 inhibitor | 0.263 0.007 DB09269 0.136 0.021 DB04325 0.071 0.047 DBMET01955 0.253 0.007 DBMET01954 | DB09269 | |
| 0.104 | 0.098 | 0.358 | Cyclooxygenase 3 inhibitor | 0.311 0.005 DB09269 0.194 0.021 DB04325 0.124 0.073 DBMET01955 0.358 0.005 DBMET01954 | DBMET01954 | |
| 0.036 | 0.031 | 0.077 | Alpha 1d adrenoreceptor agonist | 0.077 0.005 DB04325 | DB04325 | |
| 0.051 | 0.047 | 0.051 | Cathepsin B inhibitor | |||
| 0.025 | 0.021 | 0.052 | Nicotinic acid receptor 2 antagonist | 0.052 0.004 DB09269 0.03 0.014 DB04325 0.043 0.005 DBMET01954 | DB09269 | |
| 0.04 | 0.037 | 0.077 | Geranyltranstransferase inhibitor | 0.072 0.007 DB09269 0.077 0.005 DB04325 0.061 0.013 DBMET01954 | DB04325 | |
| 0.049 | 0.045 | 0.066 | Vanilloid 2 antagonist | 0.05 0.041 DB09269 0.066 0.017 DB04325 0.06 0.023 DBMET01955 0.06 0.022 DBMET01954 | DB04325 | |
| 0.032 | 0.028 | 0.123 | Kainate receptor 2 antagonist | 0.123 0.004 DB09269 0.058 0.013 DB04325 0.079 0.007 DBMET01954 | DB09269 | |
| 0.024 | 0.022 | 0.12 | Thyroid hormone agonist | 0.076 0.003 DB09269 0.041 0.006 DBMET01955 0.12 0.002 DBMET01954 | DBMET01954 | |
| 0.054 | 0.052 | 0.069 | Cyclin A1 inhibitor | 0.069 0.024 DB04325 | DB04325 | |
| 0.053 | 0.051 | 0.207 | Carbamoyl phosphate synthetase inhibitor | 0.207 0.007 DB09269 0.116 0.016 DB04325 0.169 0.009 DBMET01954 | DB09269 | |
| 0.037 | 0.034 | 0.038 | CDK5/p25 inhibitor | 0.038 0.032 DBMET01955 | DBMET01955 | |
| 0.035 | 0.033 | 0.095 | Glutamate (mGluR8) agonist | 0.095 0.003 DB09269 0.061 0.007 DB04325 0.08 0.004 DBMET01954 | DB09269 | |
| 0.044 | 0.042 | 0.119 | Glucose-6-phosphate isomerase inhibitor | 0.119 0.004 DB09269 0.054 0.024 DB04325 0.105 0.004 DBMET01954 | DB09269 | |
| 0.054 | 0.053 | 0.23 | 5 Hydroxytryptamine 2A agonist | 0.23 0.004 DB04325 | DB04325 | |
| 0.045 | 0.043 | 0.076 | Topoisomerase II beta inhibitor | 0.06 0.022 DB09269 0.056 0.025 DBMET01955 0.076 0.014 DBMET01954 | DBMET01954 | |
| 0.124 | 0.123 | 0.294 | Dual specificity phosphatase 3 inhibitor | 0.257 0.038 DB09269 0.191 0.066 DBMET01955 0.294 0.03 DBMET01954 | DBMET01954 | |
| 0.028 | 0.029 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.044 0.009 DB09269 0.044 0.009 DB04325 0.032 0.021 DBMET01954 | DB04325 | |
| 0.036 | 0.037 | 0.064 | Oxytocin agonist | 0.044 0.028 DB09269 0.064 0.014 DB04325 0.051 0.023 DBMET01955 0.057 0.019 DBMET01954 | DB04325 | |
| 0.061 | 0.064 | 0.15 | Glutamate (mGluR6) antagonist | 0.15 0.004 DB09269 0.097 0.012 DB04325 0.116 0.006 DBMET01954 | DB09269 | |
| 0.013 | 0.016 | 0.03 | Thromboxane A2 agonist | 0.03 0.003 DB09269 0.023 0.005 DBMET01954 | DB09269 | |
| 0.028 | 0.032 | 0.196 | Fumarate hydratase inhibitor | 0.196 0.003 DB09269 0.061 0.01 DB04325 0.117 0.005 DBMET01954 | DB09269 | |
| 0.047 | 0.051 | 0.231 | Argininosuccinate synthase inhibitor | 0.231 0.006 DB09269 0.128 0.014 DB04325 0.182 0.009 DBMET01954 | DB09269 | |
| 0.018 | 0.023 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DB09269 0.031 0.004 DB04325 0.025 0.008 DBMET01954 | DB04325 | |
| 0.042 | 0.047 | 0.08 | Ribonucleoside-diphosphate reductase inhibitor | 0.069 0.029 DB09269 0.049 0.041 DB04325 0.058 0.035 DBMET01955 0.08 0.025 DBMET01954 | DBMET01954 | |
| 0.013 | 0.018 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 DB04325 | DB04325 | |
| 0.052 | 0.057 | 0.157 | Purinergic P2X1 antagonist | 0.151 0.007 DB09269 0.088 0.021 DB04325 0.062 0.041 DBMET01955 0.157 0.006 DBMET01954 | DBMET01954 | |
| 0.069 | 0.074 | 0.168 | Calcium antagonist | 0.105 0.045 DB09269 0.168 0.018 DB04325 | DB04325 | |
| 0.039 | 0.044 | 0.05 | Dihydrofolate reductase inhibitor | 0.049 0.019 DB09269 0.05 0.018 DB04325 0.042 0.034 DBMET01954 | DB04325 | |
| 0.011 | 0.017 | 0.016 | Adenosine A2a receptor agonist | 0.013 0.012 DB09269 0.016 0.01 DB04325 | DB04325 | |
| 0.036 | 0.043 | 0.119 | Kainate receptor agonist | 0.119 0.002 DB09269 0.061 0.006 DB04325 0.098 0.003 DBMET01954 | DB09269 | |
| 0.051 | 0.059 | 0.088 | Sphingosine kinase inhibitor | 0.069 0.026 DB09269 0.088 0.012 DB04325 0.058 0.042 DBMET01955 0.071 0.023 DBMET01954 | DB04325 | |
| 0.021 | 0.028 | 0.066 | Lysophosphatidic acid receptor 1 agonist | 0.066 0.003 DB09269 0.033 0.009 DB04325 0.041 0.005 DBMET01954 | DB09269 | |
| 0.02 | 0.028 | 0.108 | AMPA 1 receptor antagonist | 0.108 0.005 DB09269 0.032 0.019 DB04325 0.09 0.006 DBMET01954 | DB09269 | |
| 0.135 | 0.142 | 0.398 | Phospholipase C inhibitor | 0.343 0.015 DB09269 0.354 0.014 DB04325 0.159 0.089 DBMET01955 0.398 0.01 DBMET01954 | DBMET01954 | |
| 0.062 | 0.069 | 0.114 | MDM2 inhibitor | 0.114 0.004 DB09269 0.08 0.019 DB04325 0.095 0.009 DBMET01954 | DB09269 | |
| 0.019 | 0.026 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DB04325 | DB04325 | |
| 0.041 | 0.049 | 0.081 | Ribonucleotide reductase inhibitor | 0.071 0.031 DB09269 0.053 0.04 DB04325 0.058 0.037 DBMET01955 0.081 0.026 DBMET01954 | DBMET01954 | |
| 0.01 | 0.018 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DB09269 0.016 0.005 DB04325 0.014 0.008 DBMET01954 | DB09269 | |
| 0.047 | 0.055 | 0.121 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.121 0.011 DB09269 0.076 0.022 DB04325 0.09 0.017 DBMET01954 | DB09269 | |
| 0.024 | 0.034 | 0.057 | 5 Hydroxytryptamine 6 agonist | 0.057 0.004 DB04325 | DB04325 | |
| 0.004 | 0.014 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DB09269 0.009 0.004 DBMET01954 | DB09269 | |
| 0.036 | 0.045 | 0.061 | Angiotensin AT1 receptor antagonist | 0.061 0.005 DB09269 0.04 0.033 DB04325 0.051 0.017 DBMET01954 | DB09269 | |
| 0.071 | 0.08 | 0.105 | MAP kinase kinase 7 inhibitor | 0.088 0.028 DB09269 0.102 0.011 DB04325 0.091 0.023 DBMET01955 0.105 0.009 DBMET01954 | DBMET01954 | |
| 0.066 | 0.077 | 0.094 | Vanilloid 4 agonist | 0.094 0.022 DB09269 0.084 0.034 DB04325 0.075 0.051 DBMET01954 | DB09269 | |
| 0.017 | 0.028 | 0.059 | Prostaglandin H2 antagonist | 0.059 0.003 DB09269 0.027 0.016 DB04325 0.049 0.004 DBMET01954 | DB09269 | |
| 0.08 | 0.091 | 0.273 | Carbonic anhydrase III inhibitor | 0.2 0.016 DB09269 0.224 0.013 DB04325 0.127 0.04 DBMET01955 0.273 0.007 DBMET01954 | DBMET01954 | |
| 0.06 | 0.071 | 0.115 | Thrombin inhibitor | 0.115 0.019 DB04325 | DB04325 | |
| 0.047 | 0.057 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.036 DB04325 | DB04325 | |
| 0.147 | 0.158 | 0.352 | Immunostimulant | 0.329 0.071 DB09269 0.289 0.082 DB04325 0.192 0.125 DBMET01955 0.352 0.064 DBMET01954 | DBMET01954 | |
| 0.005 | 0.016 | 0.069 | Thyroid hormone beta agonist | 0.032 0.003 DB09269 0.01 0.005 DBMET01955 0.069 0.002 DBMET01954 | DBMET01954 | |
| 0.036 | 0.047 | 0.079 | AICAR transformylase inhibitor | 0.079 0.008 DB09269 0.061 0.014 DB04325 0.074 0.009 DBMET01954 | DB09269 | |
| 0.005 | 0.016 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DB09269 0.007 0.005 DB04325 | DB04325 | |
| 0.046 | 0.057 | 0.073 | Cathepsin L inhibitor | 0.073 0.028 DB04325 | DB04325 | |
| 0.056 | 0.068 | 0.101 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DB09269 0.089 0.018 DB04325 0.073 0.03 DBMET01955 0.101 0.014 DBMET01954 | DBMET01954 | |
| 0.047 | 0.059 | 0.059 | Fatty acid synthase inhibitor | 0.059 0.036 DBMET01955 | DBMET01955 | |
| 0.026 | 0.039 | 0.078 | Phosphoglycerate kinase inhibitor | 0.048 0.015 DB09269 0.078 0.009 DB04325 0.046 0.016 DBMET01954 | DB04325 | |
| 0.029 | 0.042 | 0.054 | Cathepsin L1 inhibitor | 0.054 0.018 DB04325 | DB04325 | |
| 0.017 | 0.03 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DB09269 0.02 0.016 DB04325 | DB09269 | |
| 0.061 | 0.075 | 0.1 | Phospholipase D inhibitor | 0.1 0.014 DB09269 0.088 0.024 DB04325 0.079 0.037 DBMET01954 | DB09269 | |
| 0.067 | 0.081 | 0.233 | GABA B receptor agonist | 0.188 0.004 DB09269 0.141 0.005 DB04325 0.081 0.04 DBMET01955 0.233 0.003 DBMET01954 | DBMET01954 | |
| 0.039 | 0.053 | 0.133 | Ornithine carbamoyltransferase inhibitor | 0.133 0.011 DB09269 0.113 0.014 DB04325 0.092 0.018 DBMET01954 | DB09269 | |
| 0.006 | 0.021 | 0.024 | Thromboxane agonist | 0.024 0.003 DB09269 0.018 0.004 DBMET01954 | DB09269 | |
| 0.015 | 0.03 | 0.065 | Imidazoline I1 receptor antagonist | 0.065 0.003 DB04325 | DB04325 | |
| 0.008 | 0.024 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 DB04325 | DB04325 | |
| 0.015 | 0.031 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DB09269 0.018 0.012 DB04325 0.02 0.009 DBMET01954 | DB09269 | |
| 0.033 | 0.05 | 0.055 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DB09269 0.055 0.012 DB04325 0.041 0.03 DBMET01954 | DB04325 | |
| 0.091 | 0.108 | 0.256 | Photosensitizer | 0.256 0.005 DB09269 0.176 0.019 DB04325 0.252 0.006 DBMET01954 | DB09269 | |
| 0.061 | 0.078 | 0.151 | Glycine receptor agonist | 0.151 0.007 DB09269 0.133 0.009 DB04325 0.137 0.009 DBMET01954 | DB09269 | |
| 0.047 | 0.064 | 0.111 | Alpha 2 adrenoreceptor agonist | 0.111 0.012 DB04325 | DB04325 | |
| 0.018 | 0.035 | 0.059 | Lysine carboxypeptidase inhibitor | 0.059 0.006 DB09269 0.05 0.008 DB04325 0.048 0.008 DBMET01954 | DB09269 | |
| 0.012 | 0.029 | 0.038 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 DB09269 0.018 0.011 DB04325 0.018 0.011 DBMET01955 0.038 0.004 DBMET01954 | DBMET01954 | |
| 0.045 | 0.063 | 0.111 | Thromboxane synthase inhibitor | 0.111 0.005 DB09269 0.055 0.036 DB04325 0.094 0.007 DBMET01954 | DB09269 | |
| 0.008 | 0.026 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DB09269 | DB09269 | |
| 0.055 | 0.075 | 0.083 | Beta 2 adrenoreceptor agonist | 0.069 0.021 DB09269 0.083 0.008 DB04325 0.067 0.026 DBMET01955 0.08 0.009 DBMET01954 | DB04325 | |
| 0.018 | 0.037 | 0.117 | 5 Hydroxytryptamine 1D agonist | 0.117 0.004 DB04325 | DB04325 | |
| 0.045 | 0.065 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.011 DB09269 0.054 0.041 DB04325 0.078 0.011 DBMET01954 | DB09269 | |
| 0.035 | 0.055 | 0.107 | AMPA receptor antagonist | 0.107 0.01 DB09269 0.042 0.04 DB04325 0.087 0.015 DBMET01954 | DB09269 | |
| 0.022 | 0.042 | 0.04 | Purinergic P2Y15 antagonist | 0.029 0.018 DB09269 0.04 0.007 DB04325 | DB04325 | |
| 0.063 | 0.085 | 0.16 | Adrenaline agonist | 0.117 0.027 DB09269 0.159 0.013 DB04325 0.107 0.032 DBMET01955 0.16 0.012 DBMET01954 | DBMET01954 | |
| 0.097 | 0.118 | 0.189 | Transcription factor STAT6 inhibitor | 0.124 0.053 DB09269 0.189 0.008 DB04325 0.103 0.099 DBMET01955 0.131 0.043 DBMET01954 | DB04325 | |
| 0.016 | 0.038 | 0.025 | Factor XIII inhibitor | 0.025 0.008 DB04325 | DB04325 | |
| 0.021 | 0.043 | 0.032 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 DB09269 0.032 0.012 DB04325 0.026 0.021 DBMET01954 | DB04325 | |
| 0.094 | 0.116 | 0.24 | Toll-Like receptor 2 antagonist | 0.208 0.02 DB09269 0.187 0.03 DB04325 0.143 0.058 DBMET01955 0.24 0.011 DBMET01954 | DBMET01954 | |
| 0.083 | 0.106 | 0.133 | Glutamate (mGluR7) agonist | 0.133 0.02 DB09269 0.133 0.02 DB04325 0.102 0.056 DBMET01954 | DB04325 | |
| 0.005 | 0.028 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 DB04325 | DB04325 | |
| 0.046 | 0.069 | 0.108 | 5 Hydroxytryptamine 7 agonist | 0.108 0.006 DB04325 | DB04325 | |
| 0.02 | 0.044 | 0.046 | Thrombin receptor antagonist | 0.046 0.01 DB04325 | DB04325 | |
| 0.01 | 0.034 | 0.027 | Alpha 2a adrenoreceptor agonist | 0.027 0.006 DB04325 | DB04325 | |
| 0.025 | 0.049 | 0.053 | Angiotensin II receptor antagonist | 0.053 0.005 DB09269 0.04 0.015 DBMET01954 | DB09269 | |
| 0.042 | 0.067 | 0.071 | Dipeptidyl peptidase inhibitor | 0.071 0.017 DB04325 | DB04325 | |
| 0.006 | 0.031 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.005 DB04325 | DB04325 | |
| 0.009 | 0.034 | 0.041 | Aminopeptidase A inhibitor | 0.041 0.004 DB09269 0.019 0.012 DB04325 0.032 0.006 DBMET01954 | DB09269 | |
| 0.009 | 0.034 | 0.029 | Carbonic anhydrase X inhibitor | 0.029 0.004 DB09269 0.023 0.006 DB04325 0.017 0.011 DBMET01954 | DB09269 | |
| 0.009 | 0.034 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DB09269 0.023 0.006 DB04325 0.017 0.011 DBMET01954 | DB09269 | |
| 0.006 | 0.032 | 0.02 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DB09269 0.013 0.009 DB04325 | DB09269 | |
| 0.031 | 0.057 | 0.123 | 5 Hydroxytryptamine 2B agonist | 0.123 0.004 DB04325 | DB04325 | |
| 0.028 | 0.054 | 0.087 | GABA uptake inhibitor | 0.087 0.004 DB09269 0.063 0.009 DB04325 0.063 0.009 DBMET01954 | DB09269 | |
| 0.084 | 0.11 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 DB04325 | DB04325 | |
| 0.105 | 0.132 | 0.213 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 DB09269 0.131 0.085 DB04325 0.199 0.031 DBMET01954 | DB09269 | |
| 0.054 | 0.081 | 0.129 | Glutamate (mGluR7) antagonist | 0.129 0.004 DB09269 0.098 0.012 DB04325 0.122 0.004 DBMET01954 | DB09269 | |
| 0.066 | 0.094 | 0.287 | Potassium channel (Ca-activated) activator | 0.233 0.009 DB09269 0.105 0.051 DBMET01955 0.287 0.005 DBMET01954 | DBMET01954 | |
| 0.037 | 0.064 | 0.121 | Lysophosphatidic acid 3 receptor antagonist | 0.121 0.004 DB09269 0.06 0.022 DB04325 0.099 0.005 DBMET01954 | DB09269 | |
| 0.008 | 0.036 | 0.013 | Melatonin receptor 1A antagonist | 0.013 0.012 DB04325 | DB04325 | |
| 0.048 | 0.076 | 0.191 | 5 Hydroxytryptamine 5A antagonist | 0.191 0.005 DB04325 | DB04325 | |
| 0.087 | 0.115 | 0.225 | TRPA1 agonist | 0.2 0.01 DB09269 0.174 0.018 DB04325 0.099 0.089 DBMET01955 0.225 0.007 DBMET01954 | DBMET01954 | |
| 0.01 | 0.038 | 0.019 | Neurokinin 1 agonist | 0.019 0.015 DB04325 | DB04325 | |
| 0.018 | 0.047 | 0.076 | Arginase inhibitor | 0.068 0.008 DB09269 0.076 0.006 DB04325 0.064 0.009 DBMET01954 | DB04325 | |
| 0.084 | 0.112 | 0.342 | Cholesterol synthesis inhibitor | 0.314 0.01 DB09269 0.121 0.064 DB04325 0.11 0.075 DBMET01955 0.342 0.008 DBMET01954 | DBMET01954 | |
| 0.008 | 0.037 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DB04325 | DB04325 | |
| 0.07 | 0.1 | 0.31 | Alcohol dehydrogenase inhibitor | 0.236 0.009 DB09269 0.124 0.032 DB04325 0.103 0.049 DBMET01955 0.31 0.005 DBMET01954 | DBMET01954 | |
| 0.017 | 0.046 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DB09269 0.022 0.019 DB04325 0.028 0.008 DBMET01954 | DB09269 | |
| 0.036 | 0.066 | 0.047 | Dipeptidyl peptidase IV inhibitor | 0.047 0.025 DB04325 | DB04325 | |
| 0.013 | 0.043 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 DB04325 | DB04325 | |
| 0.118 | 0.149 | 0.192 | CF transmembrane conductance regulator agonist | 0.166 0.052 DB09269 0.178 0.038 DB04325 0.146 0.083 DBMET01955 0.192 0.027 DBMET01954 | DBMET01954 | |
| 0.02 | 0.05 | 0.033 | Complement factor 1s inhibitor | 0.024 0.022 DB09269 0.033 0.005 DB04325 | DB04325 | |
| 0.038 | 0.068 | 0.089 | Bombesin 2 receptor antagonist | 0.089 0.015 DB09269 0.068 0.02 DB04325 0.081 0.017 DBMET01954 | DB09269 | |
| 0.028 | 0.058 | 0.075 | Tryptophan 5 hydroxylase inhibitor | 0.075 0.003 DB09269 0.054 0.004 DB04325 0.055 0.004 DBMET01954 | DB09269 | |
| 0.044 | 0.075 | 0.095 | Neutrophil collagenase inhibitor | 0.095 0.024 DB09269 0.063 0.047 DB04325 0.086 0.028 DBMET01954 | DB09269 | |
| 0.005 | 0.037 | 0.027 | Glutamate (mGluR6) agonist | 0.027 0.003 DB09269 0.012 0.009 DB04325 0.024 0.004 DBMET01954 | DB09269 | |
| 0.01 | 0.042 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DB09269 0.014 0.013 DBMET01954 | DB09269 | |
| 0.187 | 0.219 | 0.627 | Histamine release inhibitor | 0.589 0.011 DB09269 0.378 0.087 DB04325 0.248 0.157 DBMET01955 0.627 0.008 DBMET01954 | DBMET01954 | |
| 0.038 | 0.071 | 0.065 | Beta adrenoreceptor agonist | 0.052 0.014 DB09269 0.054 0.012 DB04325 0.047 0.024 DBMET01955 0.065 0.006 DBMET01954 | DBMET01954 | |
| 0.033 | 0.066 | 0.146 | Thromboxane antagonist | 0.146 0.005 DB09269 0.126 0.006 DBMET01954 | DB09269 | |
| 0.05 | 0.085 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.097 0.035 DB09269 0.107 0.025 DB04325 0.1 0.032 DBMET01954 | DB04325 | |
| 0.01 | 0.045 | 0.02 | Telomerase stimulant | 0.02 0.007 DB09269 0.016 0.015 DB04325 0.02 0.008 DBMET01954 | DBMET01954 | |
| 0.044 | 0.079 | 0.127 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 DB09269 0.101 0.025 DBMET01955 0.127 0.017 DBMET01954 | DBMET01954 | |
| 0.021 | 0.056 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 DB09269 | DB09269 | |
| 0.02 | 0.056 | 0.043 | Melatonin 2 agonist | 0.043 0.014 DB04325 | DB04325 | |
| 0.014 | 0.05 | 0.059 | Prostaglandin F2 alpha agonist | 0.057 0.004 DB09269 0.025 0.013 DB04325 0.059 0.004 DBMET01954 | DBMET01954 | |
| 0.011 | 0.048 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DB09269 0.026 0.021 DB04325 | DB09269 | |
| 0.022 | 0.059 | 0.065 | Carnitine palmitoyltransferase 1 inhibitor | 0.065 0.004 DB09269 0.053 0.006 DBMET01954 | DB09269 | |
| 0.022 | 0.059 | 0.068 | Carnitine palmitoyltransferase inhibitor | 0.068 0.004 DB09269 0.055 0.006 DBMET01954 | DB09269 | |
| 0.011 | 0.049 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DB09269 | DB09269 | |
| 0.021 | 0.059 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DB09269 0.029 0.015 DB04325 0.028 0.018 DBMET01954 | DB09269 | |
| 0.028 | 0.066 | 0.039 | Histone deacetylase 9 inhibitor | 0.039 0.027 DB04325 | DB04325 | |
| 0.046 | 0.084 | 0.147 | 5 Hydroxytryptamine 3 agonist | 0.147 0.005 DB04325 | DB04325 | |
| 0.037 | 0.076 | 0.056 | Squalene epoxidase inhibitor | 0.05 0.034 DB09269 0.056 0.024 DB04325 0.053 0.028 DBMET01954 | DB04325 | |
| 0.038 | 0.077 | 0.062 | Cytokine production stimulant | 0.059 0.014 DB09269 0.062 0.011 DB04325 0.049 0.033 DBMET01954 | DB04325 | |
| 0.043 | 0.082 | 0.184 | 5 Hydroxytryptamine 5 antagonist | 0.184 0.005 DB04325 | DB04325 | |
| 0.023 | 0.062 | 0.039 | Histone deacetylase 7 inhibitor | 0.039 0.024 DB04325 | DB04325 | |
| 0.022 | 0.061 | 0.048 | Melanocortin 1 antagonist | 0.048 0.021 DB04325 | DB04325 | |
| 0.019 | 0.058 | 0.117 | Lysophosphatidic acid 2 receptor antagonist | 0.117 0.004 DB09269 0.075 0.005 DBMET01954 | DB09269 | |
| 0.037 | 0.076 | 0.105 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 DB09269 0.052 0.04 DB04325 0.064 0.026 DBMET01955 0.105 0.009 DBMET01954 | DBMET01954 | |
| 0.042 | 0.081 | 0.062 | Cyclin D1 inhibitor | 0.062 0.039 DB04325 | DB04325 | |
| 0.012 | 0.052 | 0.094 | Glutamate (mGluR1a) agonist | 0.094 0.004 DB09269 0.036 0.006 DB04325 0.049 0.005 DBMET01954 | DB09269 | |
| 0.032 | 0.072 | 0.083 | Beta 2 adrenoreceptor antagonist | 0.067 0.018 DB09269 0.073 0.015 DB04325 0.053 0.032 DBMET01955 0.083 0.011 DBMET01954 | DBMET01954 | |
| 0.008 | 0.049 | 0.025 | Cyclin T1 inhibitor | 0.025 0.007 DB04325 | DB04325 | |
| 0.038 | 0.079 | 0.067 | Matrix metalloproteinase (membrane-type) inhibitor | 0.067 0.026 DB09269 0.059 0.033 DBMET01954 | DB09269 | |
| 0.035 | 0.077 | 0.066 | Prolyl endopeptidase inhibitor | 0.066 0.019 DB09269 0.061 0.023 DB04325 0.055 0.03 DBMET01954 | DB09269 | |
| 0.116 | 0.158 | 0.161 | MAP kinase kinase 2 inhibitor | 0.161 0.111 DB04325 | DB04325 | |
| 0.024 | 0.066 | 0.059 | Glutamate (mGluR3) agonist | 0.054 0.004 DB09269 0.035 0.016 DB04325 0.059 0.004 DBMET01954 | DBMET01954 | |
| 0.013 | 0.055 | 0.022 | Bombesin agonist | 0.022 0.015 DB09269 | DB09269 | |
| 0.048 | 0.091 | 0.079 | Ryanodine receptor antagonist | 0.072 0.015 DB09269 0.066 0.024 DB04325 0.079 0.009 DBMET01954 | DBMET01954 | |
| 0.121 | 0.163 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.173 0.071 DB09269 0.165 0.08 DB04325 0.15 0.102 DBMET01954 | DB09269 | |
| 0.013 | 0.056 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 DB09269 0.043 0.01 DB04325 0.044 0.01 DBMET01954 | DB09269 | |
| 0.018 | 0.061 | 0.04 | Calcitonin receptor agonist | 0.037 0.022 DB09269 0.035 0.023 DB04325 0.04 0.02 DBMET01954 | DBMET01954 | |
| 0.023 | 0.066 | 0.041 | Carboxypeptidase B inhibitor | 0.041 0.012 DB09269 0.04 0.013 DB04325 0.035 0.019 DBMET01954 | DB09269 | |
| 0.037 | 0.08 | 0.147 | Leukotriene B4 antagonist | 0.124 0.007 DB09269 0.057 0.032 DB04325 0.147 0.005 DBMET01954 | DBMET01954 | |
| 0.05 | 0.094 | 0.099 | Histone deacetylase SIRT3 inhibitor | 0.099 0.01 DB04325 | DB04325 | |
| 0.007 | 0.052 | 0.018 | CXC chemokine 4 receptor agonist | 0.018 0.008 DB04325 | DB04325 | |
| 0.045 | 0.09 | 0.318 | Catalase inhibitor | 0.318 0.005 DB09269 0.104 0.037 DB04325 0.274 0.007 DBMET01954 | DB09269 | |
| 0.014 | 0.059 | 0.035 | Retinoid X beta receptor antagonist | 0.035 0.004 DB09269 0.026 0.006 DBMET01954 | DB09269 | |
| 0.039 | 0.084 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.029 DB09269 0.055 0.034 DB04325 | DB09269 | |
| 0.025 | 0.071 | 0.069 | Membrane dipeptidase inhibitor | 0.069 0.007 DB09269 0.047 0.018 DB04325 0.049 0.017 DBMET01954 | DB09269 | |
| 0.009 | 0.055 | 0.031 | Dopamine autoreceptor agonist | 0.031 0.013 DB04325 | DB04325 | |
| 0.011 | 0.057 | 0.035 | Sigma 2 receptor antagonist | 0.035 0.014 DB04325 | DB04325 | |
| 0.023 | 0.07 | 0.19 | Glutamate (mGluR3) antagonist | 0.19 0.004 DB09269 0.066 0.007 DB04325 0.111 0.004 DBMET01954 | DB09269 | |
| 0.021 | 0.068 | 0.072 | Dipeptidyl peptidase II inhibitor | 0.072 0.005 DB04325 | DB04325 | |
| 0.012 | 0.06 | 0.031 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DB09269 0.028 0.009 DB04325 0.031 0.008 DBMET01954 | DBMET01954 | |
| 0.122 | 0.17 | 0.181 | Heat shock protein 70 antagonist | 0.169 0.018 DB09269 0.169 0.018 DB04325 0.131 0.114 DBMET01955 0.181 0.012 DBMET01954 | DBMET01954 | |
| 0.03 | 0.078 | 0.082 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DB09269 0.067 0.034 DBMET01955 0.082 0.023 DBMET01954 | DBMET01954 | |
| 0.025 | 0.074 | 0.134 | Thromboxane A2 antagonist | 0.134 0.004 DB09269 0.11 0.006 DBMET01954 | DB09269 | |
| 0.096 | 0.145 | 0.126 | DNA repair enzyme inhibitor | 0.126 0.061 DB09269 0.121 0.069 DB04325 0.122 0.068 DBMET01954 | DB09269 | |
| 0.009 | 0.058 | 0.057 | Histamine H4 receptor agonist | 0.057 0.004 DB04325 | DB04325 | |
| 0.11 | 0.159 | 0.273 | Dual specificity phosphatase inhibitor | 0.227 0.044 DB09269 0.166 0.079 DBMET01955 0.273 0.033 DBMET01954 | DBMET01954 | |
| 0.024 | 0.074 | 0.168 | NMDA 2A receptor antagonist | 0.098 0.014 DB09269 0.168 0.005 DB04325 0.121 0.009 DBMET01954 | DB04325 | |
| 0.072 | 0.122 | 0.269 | Adenylate cyclase inhibitor | 0.191 0.027 DB09269 0.269 0.017 DB04325 0.208 0.024 DBMET01954 | DB04325 | |
| 0.012 | 0.063 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 DB09269 0.027 0.02 DBMET01954 | DB09269 | |
| 0.016 | 0.069 | 0.057 | Integrin alpha2beta1 antagonist | 0.057 0.004 DB09269 0.035 0.008 DBMET01954 | DB09269 | |
| 0.004 | 0.056 | 0.018 | Beta 3 adrenoreceptor agonist | 0.011 0.009 DB09269 0.018 0.005 DBMET01954 | DBMET01954 | |
| 0.032 | 0.084 | 0.044 | Purinergic P2X4 antagonist | 0.044 0.036 DB04325 | DB04325 | |
| 0.043 | 0.097 | 0.078 | Pregnane X receptor antagonist | 0.078 0.007 DB09269 0.056 0.04 DB04325 0.076 0.009 DBMET01954 | DB09269 | |
| 0.01 | 0.064 | 0.056 | NMDA receptor glycine site antagonist | 0.056 0.005 DB09269 0.047 0.006 DBMET01954 | DB09269 | |
| 0.106 | 0.16 | 0.141 | LIM domain kinase 1 inhibitor | 0.141 0.107 DB04325 | DB04325 | |
| 0.018 | 0.072 | 0.041 | Melatonin agonist | 0.041 0.014 DB04325 | DB04325 | |
| 0.042 | 0.096 | 0.139 | Alpha adrenoreceptor agonist | 0.139 0.018 DB04325 | DB04325 | |
| 0.092 | 0.147 | 0.216 | Sphingosine 1-phosphate receptor 4 antagonist | 0.216 0.007 DB09269 0.162 0.024 DB04325 0.188 0.012 DBMET01954 | DB09269 | |
| 0.005 | 0.059 | 0.015 | Egl nine homolog 3 inhibitor | 0.014 0.006 DB09269 0.015 0.005 DBMET01954 | DBMET01954 | |
| 0.03 | 0.085 | 0.127 | Glutamate (mGluR4) antagonist | 0.127 0.004 DB09269 0.08 0.008 DB04325 0.086 0.007 DBMET01954 | DB09269 | |
| 0.047 | 0.102 | 0.117 | Interferon inducer | 0.117 0.008 DB09269 0.088 0.018 DB04325 0.095 0.015 DBMET01954 | DB09269 | |
| 0.05 | 0.105 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.045 DB04325 0.06 0.056 DBMET01954 | DB04325 | |
| 0.113 | 0.168 | 0.148 | Aryl hydrocarbon receptor agonist | 0.148 0.137 DBMET01954 | DBMET01954 | |
| 0.017 | 0.073 | 0.043 | Myristoyl transferase inhibitor | 0.043 0.005 DB04325 | DB04325 | |
| 0.027 | 0.082 | 0.049 | Thymidine kinase inhibitor | 0.049 0.02 DB09269 0.041 0.028 DB04325 | DB09269 | |
| 0.012 | 0.068 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DB04325 | DB04325 | |
| 0.013 | 0.068 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DB09269 0.024 0.013 DB04325 0.023 0.014 DBMET01954 | DB09269 | |
| 0.031 | 0.087 | 0.04 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DB09269 0.04 0.025 DBMET01954 | DBMET01954 | |
| 0.048 | 0.104 | 0.091 | Trypsin inhibitor | 0.058 0.054 DB09269 0.091 0.022 DB04325 | DB04325 | |
| 0.008 | 0.064 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.01 DB04325 | DB04325 | |
| 0.052 | 0.109 | 0.091 | Metalloproteinase-9 inhibitor | 0.089 0.038 DB09269 0.091 0.037 DBMET01954 | DBMET01954 | |
| 0.025 | 0.082 | 0.17 | AMPA 4 receptor antagonist | 0.17 0.004 DB09269 0.064 0.009 DB04325 0.135 0.004 DBMET01954 | DB09269 | |
| 0.038 | 0.095 | 0.187 | NMDA 2 receptor antagonist | 0.099 0.032 DB09269 0.187 0.011 DB04325 0.074 0.048 DBMET01955 0.149 0.017 DBMET01954 | DB04325 | |
| 0.06 | 0.118 | 0.157 | Histamine H2 receptor antagonist | 0.157 0.009 DB04325 | DB04325 | |
| 0.019 | 0.078 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.033 DB04325 | DB04325 | |
| 0.023 | 0.082 | 0.076 | Adenosine deaminase inhibitor | 0.076 0.011 DB09269 0.064 0.018 DB04325 0.07 0.014 DBMET01954 | DB09269 | |
| 0.149 | 0.209 | 0.345 | 12-Lipoxygenase inhibitor | 0.259 0.104 DB09269 0.2 0.152 DB04325 0.248 0.11 DBMET01955 0.345 0.059 DBMET01954 | DBMET01954 | |
| 0.155 | 0.215 | 0.607 | Cholesterol antagonist | 0.571 0.022 DB09269 0.316 0.081 DB04325 0.212 0.154 DBMET01955 0.607 0.018 DBMET01954 | DBMET01954 | |
| 0.011 | 0.071 | 0.027 | CXC chemokine 5 receptor antagonist | 0.027 0.005 DB09269 0.017 0.014 DBMET01954 | DB09269 | |
| 0.041 | 0.101 | 0.238 | NMDA receptor agonist | 0.238 0.004 DB09269 0.167 0.006 DB04325 0.182 0.005 DBMET01954 | DB09269 | |
| 0.018 | 0.079 | 0.038 | Melatonin 1 agonist | 0.038 0.017 DB04325 | DB04325 | |
| 0.039 | 0.1 | 0.176 | Leukotriene antagonist | 0.162 0.009 DB09269 0.176 0.007 DBMET01954 | DBMET01954 | |
| 0.02 | 0.082 | 0.05 | Toll-Like receptor 2 agonist | 0.045 0.026 DB09269 0.05 0.024 DB04325 0.036 0.033 DBMET01954 | DB04325 | |
| 0.072 | 0.135 | 0.21 | M18 aspartyl aminopeptidase inhibitor | 0.21 0.031 DB04325 0.187 0.038 DBMET01955 0.16 0.047 DBMET01954 | DB04325 | |
| 0.016 | 0.08 | 0.151 | Retinoid X alpha receptor agonist | 0.151 0.003 DB09269 0.037 0.022 DB04325 0.127 0.004 DBMET01954 | DB09269 | |
| 0.012 | 0.076 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DB09269 0.029 0.014 DBMET01954 | DBMET01954 | |
| 0.021 | 0.086 | 0.063 | Retinoid X alpha receptor antagonist | 0.063 0.004 DB09269 0.054 0.005 DBMET01954 | DB09269 | |
| 0.041 | 0.105 | 0.06 | Kallikrein 1 inhibitor | 0.06 0.033 DB04325 | DB04325 | |
| 0.008 | 0.072 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DB04325 | DB04325 | |
| 0.035 | 0.1 | 0.121 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 DB09269 0.055 0.045 DBMET01955 0.121 0.012 DBMET01954 | DBMET01954 | |
| 0.035 | 0.1 | 0.092 | Sphingosine 1-phosphate receptor 3 antagonist | 0.092 0.01 DB09269 0.077 0.019 DB04325 0.089 0.012 DBMET01954 | DB09269 | |
| 0.029 | 0.094 | 0.082 | Leukotriene C4 antagonist | 0.082 0.004 DB09269 0.081 0.004 DBMET01954 | DB09269 | |
| 0.051 | 0.116 | 0.206 | Macrophage migration inhibitory factor inhibitor | 0.124 0.024 DB09269 0.088 0.043 DB04325 0.096 0.037 DBMET01955 0.206 0.007 DBMET01954 | DBMET01954 | |
| 0.008 | 0.074 | 0.049 | Melatonin 1 antagonist | 0.049 0.005 DB04325 | DB04325 | |
| 0.004 | 0.07 | 0.011 | Thrombopoietin agonist | 0.011 0.01 DB09269 | DB09269 | |
| 0.087 | 0.154 | 0.129 | Cytidine deaminase inhibitor | 0.129 0.092 DB09269 | DB09269 | |
| 0.015 | 0.082 | 0.103 | Free fatty acid receptor 1 antagonist | 0.103 0.003 DB09269 0.078 0.004 DBMET01954 | DB09269 | |
| 0.031 | 0.097 | 0.117 | HIV-1 integrase (Strand Transfer) inhibitor | 0.074 0.034 DB09269 0.078 0.032 DBMET01955 0.117 0.017 DBMET01954 | DBMET01954 | |
| 0.022 | 0.09 | 0.074 | Integrin alpha2 antagonist | 0.074 0.005 DB09269 0.049 0.012 DBMET01954 | DB09269 | |
| 0.024 | 0.092 | 0.062 | Fructose-1,6-bisphosphatase inhibitor | 0.062 0.016 DB09269 0.05 0.025 DB04325 0.051 0.024 DBMET01954 | DB09269 | |
| 0.071 | 0.139 | 0.158 | Alkylator | 0.146 0.048 DB09269 0.126 0.063 DB04325 0.158 0.042 DBMET01954 | DBMET01954 | |
| 0.022 | 0.09 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 DB09269 0.048 0.023 DB04325 0.059 0.012 DBMET01954 | DB09269 | |
| 0.011 | 0.08 | 0.06 | Lysophosphatidic acid 1 receptor antagonist | 0.06 0.003 DB09269 0.038 0.005 DBMET01954 | DB09269 | |
| 0.031 | 0.1 | 0.146 | NMDA receptor glycine site agonist | 0.146 0.005 DB09269 0.103 0.015 DB04325 0.118 0.009 DBMET01954 | DB09269 | |
| 0.052 | 0.122 | 0.257 | Keratolytic | 0.187 0.009 DB09269 0.1 0.03 DB04325 0.074 0.058 DBMET01955 0.257 0.005 DBMET01954 | DBMET01954 | |
| 0.023 | 0.093 | 0.072 | Retinoid X receptor antagonist | 0.072 0.004 DB09269 0.064 0.005 DBMET01954 | DB09269 | |
| 0.01 | 0.08 | 0.085 | Melatonin antagonist | 0.085 0.005 DB04325 | DB04325 | |
| 0.037 | 0.108 | 0.059 | Dopamine D1 antagonist | 0.059 0.052 DB04325 | DB04325 | |
| 0.003 | 0.075 | 0.132 | Prostaglandin EP4 agonist | 0.132 0.003 DB09269 0.114 0.003 DBMET01954 | DB09269 | |
| 0.014 | 0.086 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DB09269 0.027 0.016 DBMET01954 | DBMET01954 | |
| 0.036 | 0.108 | 0.228 | Sphingosine 1-phosphate receptor 4 agonist | 0.228 0.004 DB09269 0.122 0.016 DB04325 0.206 0.004 DBMET01954 | DB09269 | |
| 0.025 | 0.097 | 0.038 | Adenosine uptake inhibitor | 0.038 0.015 DB04325 | DB04325 | |
| 0.116 | 0.189 | 0.144 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.144 0.137 DB04325 | DB04325 | |
| 0.07 | 0.143 | 0.272 | Mucolytic | 0.253 0.006 DB09269 0.148 0.033 DB04325 0.272 0.005 DBMET01954 | DBMET01954 | |
| 0.008 | 0.082 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DB09269 0.02 0.006 DBMET01954 | DBMET01954 | |
| 0.004 | 0.078 | 0.066 | G-protein-coupled receptor 120 agonist | 0.066 0.003 DB09269 0.036 0.004 DBMET01954 | DB09269 | |
| 0.013 | 0.088 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.007 DB04325 | DB04325 | |
| 0.051 | 0.126 | 0.15 | Interferon agonist | 0.15 0.01 DB09269 0.107 0.024 DB04325 0.118 0.018 DBMET01954 | DB09269 | |
| 0.08 | 0.155 | 0.25 | NADPH oxidase inhibitor | 0.195 0.036 DB09269 0.204 0.033 DB04325 0.106 0.103 DBMET01955 0.25 0.021 DBMET01954 | DBMET01954 | |
| 0.011 | 0.087 | 0.022 | Caspase 8 inhibitor | 0.022 0.009 DB09269 0.02 0.013 DBMET01954 | DB09269 | |
| 0.119 | 0.195 | 0.476 | Interleukin agonist | 0.476 0.01 DB09269 0.344 0.031 DB04325 0.453 0.013 DBMET01954 | DB09269 | |
| 0.015 | 0.093 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.026 DB09269 | DB09269 | |
| 0.034 | 0.112 | 0.079 | 5 Hydroxytryptamine 3A antagonist | 0.079 0.032 DB04325 | DB04325 | |
| 0.042 | 0.119 | 0.16 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.123 0.028 DB09269 0.072 0.059 DB04325 0.07 0.061 DBMET01955 0.16 0.016 DBMET01954 | DBMET01954 | |
| 0.012 | 0.091 | 0.071 | Complement C3a chemotactic receptor antagonist | 0.058 0.023 DB09269 0.071 0.017 DB04325 0.037 0.035 DBMET01954 | DB04325 | |
| 0.049 | 0.127 | 0.079 | Adenosine A3 receptor antagonist | 0.068 0.061 DB09269 0.079 0.045 DB04325 | DB04325 | |
| 0.016 | 0.095 | 0.107 | ATP citrate lysase inhibitor | 0.077 0.004 DB09269 0.107 0.003 DBMET01954 | DBMET01954 | |
| 0.042 | 0.121 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | 0.068 0.064 DB09269 0.112 0.023 DB04325 | DB04325 | |
| 0.033 | 0.113 | 0.098 | Heparanase inhibitor | 0.098 0.004 DB09269 0.092 0.004 DBMET01954 | DB09269 | |
| 0.103 | 0.184 | 0.325 | Interferon gamma antagonist | 0.285 0.022 DB09269 0.145 0.085 DB04325 0.128 0.116 DBMET01955 0.325 0.017 DBMET01954 | DBMET01954 | |
| 0.087 | 0.168 | 0.26 | Acetylcholine M1 receptor antagonist | 0.149 0.076 DB09269 0.26 0.023 DB04325 0.147 0.077 DBMET01954 | DB04325 | |
| 0.011 | 0.093 | 0.125 | Retinoid X receptor agonist | 0.125 0.003 DB09269 0.108 0.004 DBMET01954 | DB09269 | |
| 0.141 | 0.223 | 0.314 | DNA synthesis inhibitor | 0.306 0.041 DB09269 0.241 0.072 DB04325 0.314 0.039 DBMET01954 | DBMET01954 | |
| 0.066 | 0.148 | 0.151 | Proteasome inhibitor | 0.151 0.046 DB09269 0.116 0.068 DB04325 0.148 0.048 DBMET01954 | DB09269 | |
| 0.014 | 0.097 | 0.093 | Glutamate (mGluR1) agonist | 0.093 0.004 DB09269 0.028 0.012 DB04325 0.049 0.005 DBMET01954 | DB09269 | |
| 0.022 | 0.105 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DB09269 | DB09269 | |
| 0.033 | 0.117 | 0.079 | Matrix metalloproteinase inhibitor | 0.079 0.038 DB09269 0.074 0.041 DBMET01954 | DB09269 | |
| 0.068 | 0.153 | 0.14 | Glutamate release inhibitor | 0.14 0.013 DB09269 0.125 0.019 DB04325 0.133 0.015 DBMET01954 | DB09269 | |
| 0.005 | 0.091 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DB09269 0.016 0.008 DBMET01954 | DB09269 | |
| 0.023 | 0.109 | 0.05 | Nerve growth factor antagonist | 0.05 0.018 DB09269 0.043 0.029 DB04325 | DB09269 | |
| 0.011 | 0.097 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.017 DB04325 | DB04325 | |
| 0.045 | 0.132 | 0.108 | Metalloproteinase-2 inhibitor | 0.108 0.035 DB09269 0.107 0.035 DBMET01954 | DB09269 | |
| 0.019 | 0.105 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 DB09269 0.033 0.029 DB04325 0.035 0.025 DBMET01954 | DB09269 | |
| 0.006 | 0.093 | 0.023 | Growth hormone releasing factor antagonist | 0.023 0.017 DB04325 | DB04325 | |
| 0.028 | 0.116 | 0.09 | 5 Hydroxytryptamine 6 antagonist | 0.09 0.018 DB04325 | DB04325 | |
| 0.011 | 0.099 | 0.098 | Liver X receptor beta antagonist | 0.092 0.004 DB09269 0.098 0.004 DBMET01954 | DBMET01954 | |
| 0.106 | 0.195 | 0.378 | Insulin sensitizer | 0.362 0.008 DB09269 0.235 0.044 DB04325 0.378 0.008 DBMET01954 | DBMET01954 | |
| 0.055 | 0.143 | 0.163 | Glutathione S-transferase inhibitor | 0.161 0.01 DB09269 0.084 0.056 DB04325 0.163 0.009 DBMET01954 | DBMET01954 | |
| 0.007 | 0.096 | 0.062 | Prostaglandin EP2 agonist | 0.062 0.004 DB09269 0.054 0.005 DBMET01954 | DB09269 | |
| 0.027 | 0.118 | 0.14 | Histamine agonist | 0.14 0.005 DB04325 | DB04325 | |
| 0.02 | 0.11 | 0.034 | Delayed rectifier potassium channel blocker | 0.034 0.032 DB04325 | DB04325 | |
| 0.018 | 0.109 | 0.089 | Glycine transporter 2 inhibitor | 0.062 0.024 DB09269 0.089 0.015 DB04325 0.081 0.017 DBMET01954 | DB04325 | |
| 0.033 | 0.125 | 0.118 | CD45 antagonist | 0.102 0.009 DB09269 0.049 0.037 DB04325 0.118 0.008 DBMET01954 | DBMET01954 | |
| 0.065 | 0.158 | 0.115 | Beta glucuronidase inhibitor | 0.094 0.08 DBMET01955 0.115 0.051 DBMET01954 | DBMET01954 | |
| 0.028 | 0.121 | 0.122 | Glutamate (mGluR group III) antagonist | 0.122 0.004 DB09269 0.063 0.012 DB04325 0.082 0.007 DBMET01954 | DB09269 | |
| 0.009 | 0.102 | 0.034 | Glucagon receptor antagonist | 0.034 0.017 DB09269 0.034 0.017 DBMET01954 | DBMET01954 | |
| 0.003 | 0.097 | 0.022 | Angiotensin AT1B receptor antagonist | 0.022 0.005 DB09269 0.013 0.01 DBMET01954 | DB09269 | |
| 0.118 | 0.212 | 0.246 | Vasodilator | 0.192 0.111 DB09269 0.246 0.071 DB04325 0.172 0.129 DBMET01955 0.233 0.08 DBMET01954 | DB04325 | |
| 0.004 | 0.098 | 0.021 | Ileal bile acid transport inhibitor | 0.018 0.01 DB09269 0.021 0.008 DBMET01954 | DBMET01954 | |
| 0.01 | 0.105 | 0.099 | Prostaglandin EP4 antagonist | 0.099 0.004 DB09269 0.067 0.006 DBMET01954 | DB09269 | |
| 0.006 | 0.102 | 0.264 | Thyroid hormone alpha antagonist | 0.264 0.002 DB09269 0.231 0.003 DBMET01954 | DB09269 | |
| 0.024 | 0.119 | 0.157 | 5 Hydroxytryptamine 2 agonist | 0.157 0.005 DB04325 | DB04325 | |
| 0.074 | 0.173 | 0.249 | Nav1.2 sodium channel blocker | 0.126 0.077 DB09269 0.249 0.022 DB04325 0.106 0.102 DBMET01954 | DB04325 | |
| 0.022 | 0.121 | 0.053 | Neurokinin 2 agonist | 0.053 0.017 DB04325 | DB04325 | |
| 0.019 | 0.119 | 0.075 | Thymidylate synthase inhibitor | 0.075 0.009 DB09269 0.068 0.013 DBMET01954 | DB09269 | |
| 0.012 | 0.113 | 0.038 | 5 Hydroxytryptamine 3B antagonist | 0.038 0.023 DB04325 | DB04325 | |
| 0.018 | 0.119 | 0.044 | Potassium channel Kv1.3 blocker | 0.044 0.036 DB09269 0.043 0.037 DBMET01954 | DB09269 | |
| 0.028 | 0.129 | 0.069 | Histamine H4 receptor antagonist | 0.069 0.013 DB04325 | DB04325 | |
| 0.017 | 0.118 | 0.066 | Antimetabolite | 0.066 0.023 DB09269 0.041 0.039 DB04325 0.053 0.03 DBMET01954 | DB09269 | |
| 0.004 | 0.105 | 0.087 | Kainate receptor 1 antagonist | 0.087 0.004 DB09269 0.049 0.005 DBMET01954 | DB09269 | |
| 0.062 | 0.164 | 0.405 | Amylase inhibitor | 0.32 0.016 DB09269 0.133 0.073 DB04325 0.117 0.083 DBMET01955 0.405 0.009 DBMET01954 | DBMET01954 | |
| 0.039 | 0.142 | 0.073 | Potassium channel (ATP-sensitive) blocker | 0.073 0.037 DB04325 | DB04325 | |
| 0.026 | 0.129 | 0.06 | Cholesterol esterase inhibitor | 0.06 0.018 DB09269 0.054 0.024 DBMET01954 | DB09269 | |
| 0.044 | 0.147 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.052 DB04325 | DB04325 | |
| 0.052 | 0.155 | 0.118 | Estrogen receptor alpha antagonist | 0.08 0.049 DB09269 0.078 0.051 DBMET01955 0.118 0.019 DBMET01954 | DBMET01954 | |
| 0.082 | 0.187 | 0.159 | Neurotrophic factor | 0.115 0.104 DB09269 0.159 0.051 DB04325 0.113 0.106 DBMET01954 | DB04325 | |
| 0.012 | 0.117 | 0.04 | Calcium-sensing receptor agonist | 0.04 0.008 DB09269 0.027 0.017 DB04325 0.025 0.021 DBMET01954 | DB09269 | |
| 0.004 | 0.11 | 0.038 | Egl nine homolog 1 inhibitor | 0.033 0.004 DB09269 0.038 0.004 DBMET01954 | DBMET01954 | |
| 0.009 | 0.115 | 0.052 | Leukotriene B4 receptor 2 antagonist | 0.052 0.004 DB09269 0.048 0.004 DBMET01954 | DB09269 | |
| 0.011 | 0.118 | 0.101 | Nicotinic acid receptor agonist | 0.088 0.005 DB09269 0.101 0.005 DBMET01954 | DBMET01954 | |
| 0.008 | 0.115 | 0.052 | 5-Alpha-reductase 2 inhibitor | 0.052 0.007 DB09269 0.037 0.008 DBMET01954 | DB09269 | |
| 0.028 | 0.135 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.035 DB09269 | DB09269 | |
| 0.036 | 0.143 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.051 DB04325 | DB04325 | |
| 0.021 | 0.129 | 0.048 | Nicotinic receptor alpha3 subunit antagonist | 0.048 0.027 DB04325 | DB04325 | |
| 0.05 | 0.158 | 0.112 | Protein kinase (CK2) alpha inhibitor | 0.112 0.067 DB09269 0.112 0.067 DBMET01954 | DBMET01954 | |
| 0.014 | 0.123 | 0.036 | Bombesin 1 receptor antagonist | 0.036 0.027 DB04325 | DB04325 | |
| 0.024 | 0.134 | 0.075 | Acetylcholine M5 receptor antagonist | 0.075 0.027 DB04325 | DB04325 | |
| 0.107 | 0.217 | 0.252 | ATPase inhibitor | 0.25 0.014 DB09269 0.145 0.11 DB04325 0.252 0.013 DBMET01954 | DBMET01954 | |
| 0.014 | 0.125 | 0.151 | Peroxisome proliferator-activated receptor alpha agonist | 0.151 0.006 DB09269 0.134 0.008 DBMET01954 | DB09269 | |
| 0.077 | 0.188 | 0.262 | Protein kinase stimulant | 0.222 0.034 DB09269 0.22 0.035 DB04325 0.262 0.024 DBMET01954 | DBMET01954 | |
| 0.051 | 0.163 | 0.169 | Anesthetic local | 0.113 0.072 DB09269 0.169 0.041 DB04325 0.095 0.088 DBMET01954 | DB04325 | |
| 0.039 | 0.151 | 0.076 | Calcium channel L-type blocker | 0.07 0.052 DB09269 0.076 0.044 DB04325 | DB04325 | |
| 0.008 | 0.12 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DB09269 | DB09269 | |
| 0.037 | 0.149 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | 0.08 0.017 DB04325 | DB04325 | |
| 0.019 | 0.132 | 0.268 | NMDA receptor subunit 3B antagonist | 0.206 0.004 DB09269 0.064 0.018 DB04325 0.268 0.004 DBMET01954 | DBMET01954 | |
| 0.002 | 0.115 | 0.014 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DB09269 0.01 0.007 DBMET01954 | DB09269 | |
| 0.024 | 0.138 | 0.064 | Acetylcholine M5 receptor agonist | 0.064 0.05 DB04325 | DB04325 | |
| 0.023 | 0.137 | 0.077 | Alpha 1 adrenoreceptor agonist | 0.077 0.024 DB04325 | DB04325 | |
| 0.019 | 0.134 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DB09269 0.05 0.048 DB04325 | DB09269 | |
| 0.058 | 0.173 | 0.174 | Acetylcholine muscarinic antagonist | 0.103 0.087 DB09269 0.174 0.032 DB04325 0.101 0.09 DBMET01954 | DB04325 | |
| 0.009 | 0.125 | 0.155 | Prostaglandin agonist | 0.155 0.004 DB09269 0.141 0.004 DBMET01954 | DB09269 | |
| 0.025 | 0.141 | 0.066 | GABA B receptor antagonist | 0.066 0.01 DB09269 0.063 0.011 DB04325 0.055 0.015 DBMET01954 | DB09269 | |
| 0.008 | 0.125 | 0.034 | Dipeptidyl peptidase I inhibitor | 0.034 0.017 DB04325 | DB04325 | |
| 0.098 | 0.214 | 0.144 | Pregnane X receptor agonist | 0.144 0.064 DB09269 0.133 0.091 DB04325 0.137 0.082 DBMET01954 | DB09269 | |
| 0.005 | 0.122 | 0.119 | Prostaglandin E2 agonist | 0.119 0.004 DB09269 0.103 0.004 DBMET01954 | DB09269 | |
| 0.035 | 0.152 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DB09269 0.078 0.019 DB04325 | DB04325 | |
| 0.037 | 0.155 | 0.076 | Epoxide hydrolase inhibitor | 0.076 0.046 DB09269 | DB09269 | |
| 0.017 | 0.135 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DB09269 | DB09269 | |
| 0.087 | 0.206 | 0.377 | Growth hormone agonist | 0.321 0.028 DB09269 0.377 0.019 DB04325 0.125 0.113 DBMET01955 0.323 0.028 DBMET01954 | DB04325 | |
| 0.005 | 0.125 | 0.023 | Complement factor D inhibitor | 0.023 0.005 DB09269 0.018 0.012 DB04325 0.017 0.015 DBMET01954 | DB09269 | |
| 0.006 | 0.126 | 0.023 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.016 DBMET01954 | DBMET01954 | |
| 0.131 | 0.252 | 0.26 | RNA-directed DNA polymerase inhibitor | 0.255 0.046 DB09269 0.222 0.072 DB04325 0.26 0.044 DBMET01954 | DBMET01954 | |
| 0.078 | 0.2 | 0.269 | Diuretic | 0.269 0.028 DB09269 0.197 0.045 DB04325 0.215 0.039 DBMET01954 | DB09269 | |
| 0.008 | 0.13 | 0.105 | AMPA 3 receptor antagonist | 0.105 0.004 DB09269 0.041 0.013 DB04325 0.068 0.005 DBMET01954 | DB09269 | |
| 0.04 | 0.162 | 0.156 | Somatostatin 1 agonist | 0.156 0.012 DB04325 0.069 0.067 DBMET01955 0.085 0.046 DBMET01954 | DB04325 | |
| 0.01 | 0.132 | 0.132 | Melanocortin 5 antagonist | 0.132 0.006 DB04325 | DB04325 | |
| 0.016 | 0.138 | 0.055 | Oleamide hydrolase inhibitor | 0.055 0.023 DB09269 0.042 0.035 DB04325 0.046 0.031 DBMET01954 | DB09269 | |
| 0.003 | 0.126 | 0.108 | Peroxisome proliferator-activated receptor alpha antagonist | 0.108 0.004 DB09269 0.089 0.005 DBMET01954 | DB09269 | |
| 0.008 | 0.132 | 0.082 | Sirtuin 2 inhibitor | 0.036 0.02 DB09269 0.082 0.005 DB04325 0.03 0.025 DBMET01954 | DB04325 | |
| 0.013 | 0.136 | 0.242 | NMDA receptor subunit 3A antagonist | 0.183 0.004 DB09269 0.05 0.02 DB04325 0.242 0.004 DBMET01954 | DBMET01954 | |
| 0.023 | 0.147 | 0.05 | Vanilloid 3 antagonist | 0.05 0.009 DB09269 0.046 0.012 DBMET01954 | DB09269 | |
| 0.022 | 0.148 | 0.038 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 DB09269 0.034 0.023 DBMET01954 | DB09269 | |
| 0.005 | 0.13 | 0.027 | 5-Alpha-reductase 1 inhibitor | 0.027 0.009 DB09269 0.018 0.011 DBMET01954 | DB09269 | |
| 0.016 | 0.143 | 0.056 | RNA-directed RNA polymerase inhibitor | 0.049 0.013 DB09269 0.056 0.011 DBMET01954 | DBMET01954 | |
| 0.023 | 0.151 | 0.091 | Dopamine uptake inhibitor | 0.091 0.021 DB04325 | DB04325 | |
| 0.005 | 0.134 | 0.048 | Sigma 1 receptor antagonist | 0.048 0.01 DB04325 | DB04325 | |
| 0.018 | 0.148 | 0.037 | Glutamate (mGluR1a) antagonist | 0.037 0.034 DB04325 | DB04325 | |
| 0.009 | 0.141 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.042 0.014 DBMET01954 | DBMET01954 | |
| 0.053 | 0.185 | 0.211 | Bile acid receptor antagonist | 0.177 0.005 DB09269 0.097 0.056 DB04325 0.211 0.004 DBMET01954 | DBMET01954 | |
| 0.081 | 0.214 | 0.202 | Hexokinase inhibitor | 0.196 0.038 DB09269 0.153 0.075 DB04325 0.202 0.034 DBMET01954 | DBMET01954 | |
| 0.046 | 0.181 | 0.279 | Expectorant | 0.249 0.013 DB09269 0.117 0.053 DB04325 0.279 0.01 DBMET01954 | DBMET01954 | |
| 0.025 | 0.16 | 0.084 | Androgen agonist | 0.071 0.03 DB09269 0.084 0.022 DBMET01954 | DBMET01954 | |
| 0.06 | 0.196 | 0.158 | Microtubule formation inhibitor | 0.158 0.034 DB09269 0.106 0.08 DB04325 0.148 0.038 DBMET01954 | DB09269 | |
| 0.023 | 0.16 | 0.105 | 5 Hydroxytryptamine 1B antagonist | 0.105 0.021 DB04325 | DB04325 | |
| 0.01 | 0.147 | 0.083 | TRPM8 blocker | 0.036 0.03 DB09269 0.083 0.008 DB04325 | DB04325 | |
| 0.003 | 0.14 | 0.014 | Integrin beta2 antagonist | 0.014 0.008 DB09269 | DB09269 | |
| 0.068 | 0.205 | 0.158 | Toll-Like receptor antagonist | 0.158 0.05 DB04325 | DB04325 | |
| 0.017 | 0.154 | 0.04 | Glutamate (mGluR4) agonist | 0.04 0.016 DB09269 0.032 0.027 DBMET01954 | DB09269 | |
| 0.042 | 0.179 | 0.145 | Peroxisome proliferator-activated receptor gamma antagonist | 0.145 0.006 DB09269 0.129 0.008 DBMET01954 | DB09269 | |
| 0.016 | 0.154 | 0.154 | NMDA 2C receptor antagonist | 0.134 0.008 DB09269 0.152 0.007 DB04325 0.154 0.006 DBMET01954 | DBMET01954 | |
| 0.01 | 0.148 | 0.031 | LFA antagonist | 0.031 0.014 DB09269 0.025 0.024 DB04325 | DB09269 | |
| 0.019 | 0.159 | 0.095 | Acetylcholine M3 receptor antagonist | 0.095 0.019 DB04325 0.052 0.051 DBMET01954 | DB04325 | |
| 0.011 | 0.152 | 0.025 | 5 Hydroxytryptamine 4 agonist | 0.025 0.015 DB04325 | DB04325 | |
| 0.103 | 0.245 | 0.431 | Antioxidant | 0.252 0.082 DB09269 0.306 0.059 DBMET01955 0.431 0.03 DBMET01954 | DBMET01954 | |
| 0.013 | 0.155 | 0.078 | Phosphorylase inhibitor | 0.078 0.017 DB09269 0.071 0.02 DBMET01954 | DB09269 | |
| 0.019 | 0.162 | 0.082 | Acetylcholine M2 receptor antagonist | 0.082 0.028 DB04325 | DB04325 | |
| 0.007 | 0.15 | 0.073 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 DB09269 0.041 0.009 DBMET01954 | DB09269 | |
| 0.053 | 0.197 | 0.083 | mTOR complex 2 inhibitor | 0.083 0.061 DB04325 | DB04325 | |
| 0.017 | 0.162 | 0.143 | Liver X receptor alpha agonist | 0.126 0.004 DB09269 0.143 0.004 DBMET01954 | DBMET01954 | |
| 0.061 | 0.206 | 0.096 | Phosphodiesterase 6D inhibitor | 0.092 0.071 DB09269 0.087 0.086 DB04325 0.096 0.062 DBMET01954 | DBMET01954 | |
| 0.02 | 0.167 | 0.146 | 5 Hydroxytryptamine 1D antagonist | 0.146 0.012 DB04325 | DB04325 | |
| 0.015 | 0.163 | 0.076 | Aminopeptidase N inhibitor | 0.076 0.018 DB09269 0.047 0.035 DB04325 0.056 0.027 DBMET01954 | DB09269 | |
| 0.018 | 0.168 | 0.06 | 5 Hydroxytryptamine 4 antagonist | 0.06 0.023 DB04325 | DB04325 | |
| 0.028 | 0.18 | 0.106 | Carbonic anhydrase II stimulant | 0.106 0.005 DB04325 | DB04325 | |
| 0.022 | 0.175 | 0.096 | Aminopeptidase microsomal inhibitor | 0.096 0.019 DB09269 0.066 0.035 DB04325 0.078 0.026 DBMET01954 | DB09269 | |
| 0.025 | 0.178 | 0.096 | Amidase inhibitor | 0.095 0.027 DB09269 0.07 0.048 DB04325 0.096 0.027 DBMET01954 | DBMET01954 | |
| 0.01 | 0.163 | 0.1 | Liver X receptor beta agonist | 0.1 0.005 DB09269 0.093 0.005 DBMET01954 | DB09269 | |
| 0.011 | 0.164 | 0.078 | Sphingosine 1-phosphate receptor 1 agonist | 0.078 0.006 DB09269 0.053 0.017 DB04325 0.066 0.01 DBMET01954 | DB09269 | |
| 0.004 | 0.157 | 0.027 | Neutral endopeptidase inhibitor | 0.027 0.013 DB09269 | DB09269 | |
| 0.024 | 0.177 | 0.049 | Aldosterone antagonist | 0.049 0.03 DB09269 | DB09269 | |
| 0.087 | 0.241 | 0.203 | Tumour necrosis factor antagonist | 0.203 0.051 DB04325 | DB04325 | |
| 0.008 | 0.162 | 0.12 | Peroxisome proliferator-activated receptor delta agonist | 0.12 0.005 DB09269 0.092 0.006 DBMET01954 | DB09269 | |
| 0.018 | 0.172 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.025 DB09269 0.032 0.026 DBMET01954 | DBMET01954 | |
| 0.007 | 0.163 | 0.051 | HCV NS5B polymerase inhibitor | 0.041 0.014 DB09269 0.051 0.01 DBMET01954 | DBMET01954 | |
| 0.031 | 0.187 | 0.165 | 5 Hydroxytryptamine 2C antagonist | 0.165 0.023 DB04325 | DB04325 | |
| 0.045 | 0.202 | 0.209 | Uric acid excretion stimulant | 0.189 0.014 DB09269 0.084 0.075 DBMET01955 0.209 0.012 DBMET01954 | DBMET01954 | |
| 0.025 | 0.182 | 0.088 | Acetylcholine M4 receptor antagonist | 0.088 0.039 DB04325 | DB04325 | |
| 0.003 | 0.162 | 0.027 | Integrin alpha4beta1 antagonist | 0.027 0.008 DB09269 0.019 0.01 DBMET01954 | DB09269 | |
| 0.05 | 0.209 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.077 DB04325 | DB04325 | |
| 0.02 | 0.18 | 0.065 | Nicotinic receptor alpha7 subunit antagonist | 0.065 0.025 DB04325 | DB04325 | |
| 0.058 | 0.218 | 0.361 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.361 0.009 DB04325 | DB04325 | |
| 0.01 | 0.171 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DB09269 0.028 0.027 DBMET01954 | DB09269 | |
| 0.008 | 0.169 | 0.091 | 5-Alpha-reductase inhibitor | 0.091 0.011 DB09269 0.082 0.012 DBMET01954 | DB09269 | |
| 0.023 | 0.184 | 0.092 | Neuronal nicotinic receptor antagonist | 0.092 0.028 DB04325 | DB04325 | |
| 0.032 | 0.194 | 0.085 | Protein kinase (CK2) inhibitor | 0.085 0.077 DB09269 0.085 0.077 DBMET01954 | DBMET01954 | |
| 0.042 | 0.204 | 0.142 | Bronchodilator | 0.105 0.058 DB09269 0.113 0.049 DB04325 0.142 0.034 DBMET01954 | DBMET01954 | |
| 0.02 | 0.182 | 0.069 | Glutamate (mGluR group III) agonist | 0.069 0.015 DB09269 0.043 0.029 DBMET01954 | DB09269 | |
| 0.048 | 0.213 | 0.169 | Interleukin 1 beta converting enzyme inhibitor | 0.169 0.011 DB09269 0.096 0.063 DB04325 0.164 0.013 DBMET01954 | DB09269 | |
| 0.005 | 0.17 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DB09269 | DB09269 | |
| 0.028 | 0.194 | 0.083 | Sphingosine 1-phosphate receptor 1 antagonist | 0.083 0.013 DB09269 0.075 0.016 DBMET01954 | DB09269 | |
| 0.014 | 0.18 | 0.078 | 5 Hydroxytryptamine 1A antagonist | 0.078 0.041 DB04325 | DB04325 | |
| 0.012 | 0.179 | 0.106 | Carbonic anhydrase I stimulant | 0.106 0.004 DB04325 | DB04325 | |
| 0.028 | 0.195 | 0.125 | Acetylcholine nicotinic antagonist | 0.125 0.029 DB04325 | DB04325 | |
| 0.018 | 0.186 | 0.047 | Potassium channel (Inward rectifier) blocker | 0.047 0.039 DB04325 | DB04325 | |
| 0.013 | 0.181 | 0.068 | Aromatase inhibitor | 0.068 0.035 DBMET01954 | DBMET01954 | |
| 0.024 | 0.193 | 0.548 | 5 Hydroxytryptamine 1B agonist | 0.548 0.003 DB04325 | DB04325 | |
| 0.017 | 0.186 | 0.05 | Dihydroorotase inhibitor | 0.05 0.025 DB09269 | DB09269 | |
| 0.018 | 0.188 | 0.07 | Neuropeptide agonist | 0.07 0.035 DB04325 | DB04325 | |
| 0.061 | 0.232 | 0.155 | Antibacterial (Helicobacter pylori) | 0.155 0.042 DB09269 0.139 0.057 DB04325 0.154 0.043 DBMET01954 | DB09269 | |
| 0.05 | 0.221 | 0.17 | Acetylcholine antagonist | 0.17 0.04 DB04325 | DB04325 | |
| 0.026 | 0.199 | 0.071 | Rho-associated kinase I inhibitor | 0.071 0.056 DB04325 | DB04325 | |
| 0.05 | 0.223 | 0.173 | Cholinergic antagonist | 0.173 0.041 DB04325 | DB04325 | |
| 0.025 | 0.199 | 0.062 | Histone deacetylase inhibitor | 0.062 0.051 DB04325 | DB04325 | |
| 0.047 | 0.221 | 0.094 | Protein kinase C zeta inhibitor | 0.094 0.058 DB04325 0.082 0.081 DBMET01954 | DB04325 | |
| 0.04 | 0.216 | 0.105 | Chymotrypsin inhibitor | 0.105 0.033 DB09269 0.086 0.047 DB04325 0.089 0.044 DBMET01954 | DB09269 | |
| 0.008 | 0.185 | 0.033 | Urotensin II agonist | 0.027 0.018 DB09269 0.033 0.013 DB04325 0.028 0.017 DBMET01954 | DB04325 | |
| 0.018 | 0.196 | 0.057 | 5 Hydroxytryptamine 3 antagonist | 0.057 0.04 DB04325 | DB04325 | |
| 0.044 | 0.223 | 0.141 | Alpha 2c adrenoreceptor antagonist | 0.141 0.037 DB04325 | DB04325 | |
| 0.042 | 0.222 | 0.171 | 5 Hydroxytryptamine 2B antagonist | 0.171 0.033 DB04325 | DB04325 | |
| 0.034 | 0.215 | 0.218 | Potassium channel large-conductance Ca-activated activator | 0.185 0.007 DB09269 0.218 0.005 DBMET01954 | DBMET01954 | |
| 0.072 | 0.255 | 0.147 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.083 DB04325 | DB04325 | |
| 0.039 | 0.223 | 0.109 | Gastric antisecretory | 0.109 0.054 DB09269 0.096 0.07 DBMET01954 | DB09269 | |
| 0.015 | 0.199 | 0.096 | Sphingosine 1-phosphate receptor agonist | 0.096 0.006 DB09269 0.051 0.024 DB04325 0.075 0.01 DBMET01954 | DB09269 | |
| 0.066 | 0.251 | 0.115 | Factor V inhibitor | 0.098 0.074 DB09269 0.115 0.044 DB04325 | DB04325 | |
| 0.062 | 0.248 | 0.273 | Interleukin 8 antagonist | 0.267 0.005 DB09269 0.153 0.032 DB04325 0.273 0.005 DBMET01954 | DBMET01954 | |
| 0.018 | 0.204 | 0.089 | 5 Hydroxytryptamine 1 antagonist | 0.089 0.042 DB04325 | DB04325 | |
| 0.015 | 0.204 | 0.083 | Toll-Like receptor 8 antagonist | 0.083 0.016 DB04325 | DB04325 | |
| 0.013 | 0.202 | 0.044 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DB09269 | DB09269 | |
| 0.007 | 0.197 | 0.117 | Urate transporter 1 inhibitor | 0.117 0.005 DB09269 0.111 0.005 DBMET01954 | DB09269 | |
| 0.046 | 0.237 | 0.166 | Nav1.6 sodium channel blocker | 0.126 0.086 DB09269 0.166 0.038 DB04325 | DB04325 | |
| 0.01 | 0.204 | 0.062 | Melanocortin 4 antagonist | 0.062 0.018 DB04325 | DB04325 | |
| 0.021 | 0.217 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.032 DB04325 | DB04325 | |
| 0.005 | 0.201 | 0.035 | G protein-coupled receptor agonist | 0.035 0.029 DB09269 | DB09269 | |
| 0.008 | 0.203 | 0.057 | Estradiol 17 beta-dehydrogenase inhibitor | 0.057 0.021 DBMET01954 | DBMET01954 | |
| 0.038 | 0.234 | 0.096 | Caspase 7 inhibitor | 0.096 0.034 DB09269 0.085 0.05 DBMET01954 | DB09269 | |
| 0.041 | 0.238 | 0.165 | Alpha 2b adrenoreceptor antagonist | 0.165 0.033 DB04325 | DB04325 | |
| 0.047 | 0.245 | 0.152 | Caspase 3 inhibitor | 0.152 0.027 DB09269 0.148 0.03 DBMET01954 | DB09269 | |
| 0.098 | 0.296 | 0.394 | Thyroid hormone antagonist | 0.374 0.065 DB09269 0.394 0.058 DBMET01954 | DBMET01954 | |
| 0.004 | 0.207 | 0.019 | Growth hormone release promoting | 0.019 0.014 DB04325 | DB04325 | |
| 0.017 | 0.221 | 0.122 | Plasmin inhibitor | 0.122 0.014 DB04325 | DB04325 | |
| 0.005 | 0.21 | 0.072 | Leukotriene B4 receptor 1 antagonist | 0.072 0.004 DB09269 0.063 0.005 DBMET01954 | DB09269 | |
| 0.018 | 0.225 | 0.127 | 5 Hydroxytryptamine 2A antagonist | 0.127 0.035 DB04325 | DB04325 | |
| 0.018 | 0.225 | 0.075 | Collagenase 3 inhibitor | 0.075 0.028 DB09269 0.059 0.043 DBMET01954 | DB09269 | |
| 0.013 | 0.221 | 0.085 | Melanocortin antagonist | 0.085 0.013 DB04325 | DB04325 | |
| 0.038 | 0.249 | 0.157 | Aminoacyl-tRNA synthetase inhibitor | 0.157 0.017 DB04325 0.083 0.071 DBMET01954 | DB04325 | |
| 0.035 | 0.247 | 0.101 | Sphingosine 1-phosphate receptor antagonist | 0.101 0.021 DB09269 0.097 0.024 DBMET01954 | DB09269 | |
| 0.011 | 0.224 | 0.046 | Adenosine A2b receptor antagonist | 0.046 0.039 DB04325 | DB04325 | |
| 0.018 | 0.234 | 0.046 | Neurotensin receptor antagonist | 0.043 0.033 DB04325 0.046 0.031 DBMET01954 | DBMET01954 | |
| 0.012 | 0.228 | 0.062 | Alpha 1b adrenoreceptor antagonist | 0.062 0.059 DB04325 | DB04325 | |
| 0.013 | 0.232 | 0.055 | Growth hormone release inhibitor | 0.055 0.019 DB04325 | DB04325 | |
| 0.005 | 0.226 | 0.059 | Thyroid hormone alpha agonist | 0.059 0.003 DB09269 0.055 0.003 DBMET01954 | DB09269 | |
| 0.019 | 0.241 | 0.105 | Histamine H1 receptor antagonist | 0.081 0.056 DB09269 0.105 0.039 DB04325 | DB04325 | |
| 0.009 | 0.233 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.032 DB09269 | DB09269 | |
| 0.01 | 0.234 | 0.334 | Prostaglandin EP2 antagonist | 0.334 0.004 DB09269 0.25 0.005 DBMET01954 | DB09269 | |
| 0.012 | 0.238 | 0.097 | Somatostatin 5 agonist | 0.097 0.005 DB04325 | DB04325 | |
| 0.007 | 0.235 | 0.043 | Growth hormone releasing factor agonist | 0.043 0.016 DB04325 | DB04325 | |
| 0.016 | 0.244 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 DB04325 | DB04325 | |
| 0.027 | 0.256 | 0.141 | Alpha 2 adrenoreceptor antagonist | 0.141 0.03 DB04325 | DB04325 | |
| 0.041 | 0.271 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 DB04325 | DB04325 | |
| 0.086 | 0.315 | 0.314 | DNA damaging | 0.229 0.093 DB09269 0.314 0.052 DB04325 0.239 0.087 DBMET01954 | DB04325 | |
| 0.075 | 0.306 | 0.133 | MAP kinase 3 inhibitor | 0.133 0.099 DB09269 | DB09269 | |
| 0.012 | 0.243 | 0.104 | Opioid delta receptor antagonist | 0.087 0.034 DB04325 0.104 0.029 DBMET01954 | DBMET01954 | |
| 0.072 | 0.304 | 0.443 | Non-steroidal antiinflammatory agent | 0.439 0.01 DB09269 0.181 0.087 DB04325 0.443 0.009 DBMET01954 | DBMET01954 | |
| 0.05 | 0.284 | 0.116 | Calcium channel blocker | 0.116 0.092 DB04325 | DB04325 | |
| 0.015 | 0.25 | 0.16 | Selectin antagonist | 0.16 0.016 DB09269 0.156 0.017 DBMET01954 | DB09269 | |
| 0.049 | 0.286 | 0.125 | Nav1.5 sodium channel blocker | 0.125 0.049 DB04325 | DB04325 | |
| 0.026 | 0.263 | 0.164 | 5 Hydroxytryptamine 2 antagonist | 0.164 0.04 DB04325 | DB04325 | |
| 0.028 | 0.266 | 0.104 | Antihistaminic | 0.104 0.052 DB04325 | DB04325 | |
| 0.022 | 0.261 | 0.095 | Histamine antagonist | 0.095 0.051 DB04325 | DB04325 | |
| 0.031 | 0.27 | 0.122 | Opioid antagonist | 0.122 0.035 DB04325 0.08 0.069 DBMET01955 0.116 0.038 DBMET01954 | DB04325 | |
| 0.01 | 0.252 | 0.058 | Leukocyte elastase inhibitor | 0.058 0.019 DB09269 0.044 0.029 DBMET01954 | DB09269 | |
| 0.031 | 0.273 | 0.184 | Mediator release inhibitor | 0.157 0.026 DB09269 0.184 0.018 DBMET01954 | DBMET01954 | |
| 0.023 | 0.267 | 0.115 | Alpha 2a adrenoreceptor antagonist | 0.115 0.03 DB04325 | DB04325 | |
| 0.131 | 0.377 | 0.262 | Ca(v)3.3 blocker | 0.262 0.083 DB04325 | DB04325 | |
| 0.005 | 0.252 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 DB09269 0.041 0.023 DBMET01954 | DB09269 | |
| 0.058 | 0.305 | 0.285 | Anticonvulsant | 0.244 0.059 DB09269 0.285 0.045 DB04325 0.142 0.139 DBMET01954 | DB04325 | |
| 0.015 | 0.265 | 0.12 | Diacylglycerol O-acyltransferase inhibitor | 0.12 0.005 DB09269 0.083 0.013 DBMET01954 | DB09269 | |
| 0.021 | 0.276 | 0.083 | Alpha adrenoreceptor antagonist | 0.083 0.069 DB04325 | DB04325 | |
| 0.023 | 0.279 | 0.085 | Analgesic, opioid | 0.072 0.058 DB04325 0.085 0.042 DBMET01954 | DBMET01954 | |
| 0.018 | 0.275 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET01954 | DBMET01954 | |
| 0.005 | 0.267 | 0.043 | Glutamate (mGluR group II) antagonist | 0.043 0.022 DB09269 | DB09269 | |
| 0.014 | 0.276 | 0.051 | Pim-2 kinase inhibitor | 0.051 0.043 DB04325 | DB04325 | |
| 0.012 | 0.275 | 0.098 | Opioid mu receptor antagonist | 0.094 0.034 DB04325 0.098 0.032 DBMET01954 | DBMET01954 | |
| 0.054 | 0.319 | 0.141 | I kappa B kinase epsilon inhibitor | 0.141 0.13 DB04325 | DB04325 | |
| 0.025 | 0.29 | 0.073 | Secretase beta inhibitor | 0.073 0.045 DB04325 | DB04325 | |
| 0.003 | 0.271 | 0.082 | Integrin beta7 antagonist | 0.082 0.005 DB09269 0.046 0.007 DBMET01954 | DB09269 | |
| 0.077 | 0.348 | 0.343 | Thyroid hormone beta antagonist | 0.326 0.077 DB09269 0.343 0.071 DBMET01954 | DBMET01954 | |
| 0.018 | 0.295 | 0.076 | Androgen antagonist | 0.076 0.071 DBMET01954 | DBMET01954 | |
| 0.021 | 0.297 | 0.134 | 5 Hydroxytryptamine antagonist | 0.134 0.057 DB04325 | DB04325 | |
| 0.063 | 0.34 | 0.217 | Hemostatic | 0.183 0.041 DB09269 0.217 0.027 DB04325 0.18 0.042 DBMET01954 | DB04325 | |
| 0.006 | 0.283 | 0.019 | Integrin beta6 antagonist | 0.018 0.005 DB09269 0.019 0.004 DBMET01954 | DBMET01954 | |
| 0.009 | 0.287 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DB09269 0.035 0.025 DBMET01954 | DBMET01954 | |
| 0.019 | 0.298 | 0.077 | I kappa B kinase 2 inhibitor | 0.077 0.024 DB04325 | DB04325 | |
| 0.01 | 0.289 | 0.059 | Alpha tubulin antagonist | 0.059 0.032 DBMET01954 | DBMET01954 | |
| 0.058 | 0.341 | 0.314 | Platelet adhesion inhibitor | 0.314 0.03 DB09269 0.314 0.029 DBMET01954 | DBMET01954 | |
| 0.052 | 0.337 | 0.156 | Amyloid beta precursor protein antagonist | 0.156 0.095 DBMET01954 | DBMET01954 | |
| 0.002 | 0.287 | 0.013 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.012 DB09269 | DB09269 | |
| 0.06 | 0.349 | 0.154 | Sigma receptor agonist | 0.154 0.083 DB04325 | DB04325 | |
| 0.011 | 0.302 | 0.091 | Prostaglandin-E synthase inhibitor | 0.091 0.032 DB09269 0.077 0.041 DBMET01954 | DB09269 | |
| 0.005 | 0.298 | 0.055 | Carnitine palmitoyltransferase 1A inhibitor | 0.055 0.006 DB09269 0.039 0.01 DBMET01954 | DB09269 | |
| 0.031 | 0.328 | 0.213 | Chelator | 0.115 0.059 DB09269 0.103 0.073 DBMET01955 0.213 0.022 DBMET01954 | DBMET01954 | |
| 0.016 | 0.316 | 0.064 | Glutamate (mGluR8) antagonist | 0.064 0.005 DB09269 0.038 0.02 DB04325 0.051 0.008 DBMET01954 | DB09269 | |
| 0.006 | 0.307 | 0.04 | Purinergic P2Y antagonist | 0.04 0.036 DB09269 | DB09269 | |
| 0.023 | 0.332 | 0.097 | Protease inhibitor | 0.097 0.068 DB09269 | DB09269 | |
| 0.007 | 0.315 | 0.029 | Somatostatin 4 antagonist | 0.029 0.012 DB04325 | DB04325 | |
| 0.025 | 0.337 | 0.156 | DNA helicase inhibitor | 0.156 0.003 DB09269 0.13 0.004 DBMET01954 | DB09269 | |
| 0.094 | 0.408 | 0.456 | Sodium/bile acid cotransporter inhibitor | 0.453 0.007 DB09269 0.279 0.099 DBMET01955 0.456 0.007 DBMET01954 | DBMET01954 | |
| 0.115 | 0.439 | 0.719 | Cyclophilin D inhibitor | 0.719 0.012 DB09269 0.675 0.017 DBMET01954 | DB09269 | |
| 0.005 | 0.331 | 0.475 | 5 Hydroxytryptamine 1 agonist | 0.475 0.004 DB04325 | DB04325 | |
| 0.03 | 0.357 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.079 DB04325 | DB04325 | |
| 0.035 | 0.367 | 0.192 | DNA polymerase I inhibitor | 0.159 0.044 DB09269 0.116 0.072 DB04325 0.192 0.031 DBMET01954 | DBMET01954 | |
| 0.028 | 0.365 | 0.187 | AMP-activated protein kinase stimulant | 0.164 0.02 DB09269 0.187 0.013 DBMET01954 | DBMET01954 | |
| 0.003 | 0.344 | 0.045 | Integrin beta3 antagonist | 0.045 0.007 DB09269 0.017 0.016 DBMET01954 | DB09269 | |
| 0.007 | 0.349 | 0.048 | Opioid agonist | 0.048 0.042 DBMET01954 | DBMET01954 | |
| 0.004 | 0.346 | 0.028 | Cholecystokinin B antagonist | 0.028 0.024 DB09269 | DB09269 | |
| 0.021 | 0.363 | 0.097 | I kappa B kinase inhibitor | 0.097 0.041 DB04325 | DB04325 | |
| 0.007 | 0.351 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DB09269 0.017 0.013 DB04325 0.017 0.012 DBMET01954 | DB09269 | |
| 0.018 | 0.364 | 0.101 | Elastase 1 inhibitor | 0.101 0.019 DB09269 0.096 0.022 DBMET01954 | DB09269 | |
| 0.013 | 0.359 | 0.065 | Angiotensin-converting enzyme inhibitor | 0.065 0.024 DB09269 0.059 0.032 DBMET01954 | DB09269 | |
| 0.08 | 0.427 | 0.286 | Catenin beta inhibitor | 0.271 0.008 DB09269 0.138 0.137 DB04325 0.286 0.006 DBMET01954 | DBMET01954 | |
| 0.011 | 0.363 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 DB04325 | DB04325 | |
| 0.003 | 0.355 | 0.077 | Integrin alpha4beta7 antagonist | 0.077 0.004 DB09269 0.043 0.005 DBMET01954 | DB09269 | |
| 0.008 | 0.36 | 0.079 | Tryptase inhibitor | 0.079 0.006 DB04325 | DB04325 | |
| 0.006 | 0.359 | 0.052 | Opioid mu receptor agonist | 0.052 0.027 DBMET01954 | DBMET01954 | |
| 0.008 | 0.361 | 0.066 | Somatostatin 1 antagonist | 0.066 0.013 DB04325 | DB04325 | |
| 0.007 | 0.363 | 0.312 | Peroxisome proliferator-activated receptor delta antagonist | 0.312 0.003 DB09269 0.247 0.004 DBMET01954 | DB09269 | |
| 0.103 | 0.463 | 0.521 | Interleukin 2 agonist | 0.521 0.006 DB09269 0.374 0.036 DB04325 0.199 0.192 DBMET01955 0.5 0.008 DBMET01954 | DB09269 | |
| 0.004 | 0.364 | 0.127 | Leukotriene A4 hydrolase inhibitor | 0.039 0.026 DB09269 0.127 0.005 DB04325 | DB04325 | |
| 0.005 | 0.365 | 0.05 | Integrin beta5 antagonist | 0.05 0.005 DB09269 0.025 0.01 DBMET01954 | DB09269 | |
| 0.005 | 0.367 | 0.115 | Prostacyclin antagonist | 0.115 0.004 DB09269 0.079 0.005 DBMET01954 | DB09269 | |
| 0.037 | 0.401 | 0.14 | Cytokine production inhibitor | 0.14 0.07 DB04325 | DB04325 | |
| 0.121 | 0.486 | 0.228 | MAP kinase kinase 3 inhibitor | 0.228 0.059 DB04325 | DB04325 | |
| 0.004 | 0.371 | 0.069 | Squalene synthetase inhibitor | 0.069 0.01 DB09269 0.051 0.014 DBMET01954 | DB09269 | |
| 0.004 | 0.371 | 0.182 | GP IIb/IIIa receptor antagonist | 0.182 0.008 DB09269 0.046 0.036 DB04325 0.094 0.019 DBMET01954 | DB09269 | |
| 0.04 | 0.412 | 0.15 | Toll-Like receptor 3 antagonist | 0.15 0.014 DB04325 | DB04325 | |
| 0.06 | 0.439 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.072 DB09269 0.118 0.058 DB04325 0.105 0.087 DBMET01954 | DB04325 | |
| 0.009 | 0.388 | 0.097 | Glutamate receptor agonist | 0.097 0.039 DB09269 0.087 0.047 DB04325 | DB09269 | |
| 0.01 | 0.391 | 0.05 | Erythropoietin receptor agonist | 0.042 0.027 DB09269 0.05 0.022 DBMET01954 | DBMET01954 | |
| 0.012 | 0.399 | 0.138 | Leukotriene synthesis inhibitor | 0.13 0.013 DB09269 0.138 0.011 DBMET01954 | DBMET01954 | |
| 0.026 | 0.412 | 0.122 | GABA receptor agonist | 0.122 0.055 DB09269 0.116 0.06 DB04325 0.094 0.084 DBMET01954 | DB09269 | |
| 0.006 | 0.393 | 0.042 | Nicotinic acid receptor 2 agonist | 0.036 0.024 DB09269 0.042 0.018 DBMET01954 | DBMET01954 | |
| 0.014 | 0.404 | 0.084 | Protein kinase C iota inhibitor | 0.084 0.024 DB04325 | DB04325 | |
| 0.003 | 0.394 | 0.11 | Retinoid X beta receptor agonist | 0.11 0.003 DB09269 0.057 0.004 DBMET01954 | DB09269 | |
| 0.017 | 0.408 | 0.126 | Antiadrenergic | 0.126 0.043 DB04325 | DB04325 | |
| 0.044 | 0.436 | 0.365 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.365 0.024 DB04325 | DB04325 | |
| 0.004 | 0.398 | 0.102 | Retinoid X gamma receptor agonist | 0.102 0.004 DB09269 0.054 0.005 DBMET01954 | DB09269 | |
| 0.007 | 0.401 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 DB09269 | DB09269 | |
| 0.03 | 0.427 | 0.058 | Heme oxygenase stimulant | 0.058 0.053 DBMET01954 | DBMET01954 | |
| 0.067 | 0.465 | 0.192 | Death-associated protein kinase 2 inhibitor | 0.192 0.041 DB04325 | DB04325 | |
| 0.003 | 0.401 | 0.097 | Estrogen receptor alpha agonist | 0.037 0.022 DBMET01955 0.097 0.009 DBMET01954 | DBMET01954 | |
| 0.013 | 0.415 | 0.145 | Protein kinase A inhibitor | 0.145 0.026 DB04325 | DB04325 | |
| 0.004 | 0.415 | 0.051 | Somatostatin 2 antagonist | 0.051 0.015 DB04325 | DB04325 | |
| 0.008 | 0.419 | 0.112 | Dopamine agonist | 0.112 0.023 DB04325 | DB04325 | |
| 0.023 | 0.435 | 0.156 | Mcl-1 antagonist | 0.156 0.084 DBMET01954 | DBMET01954 | |
| 0.003 | 0.415 | 0.123 | VLA-4 antagonist | 0.123 0.005 DB09269 0.095 0.006 DBMET01954 | DB09269 | |
| 0.004 | 0.42 | 0.047 | Cholecystokinin antagonist | 0.047 0.026 DB09269 | DB09269 | |
| 0.014 | 0.431 | 0.167 | Protein kinase B gamma inhibitor | 0.167 0.012 DB04325 | DB04325 | |
| 0.004 | 0.423 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DB09269 0.025 0.011 DBMET01954 | DB09269 | |
| 0.027 | 0.45 | 0.139 | Beta amyloid protein antagonist | 0.096 0.095 DB09269 0.139 0.049 DB04325 | DB04325 | |
| 0.105 | 0.529 | 0.253 | MAP kinase kinase 6 inhibitor | 0.253 0.186 DB04325 | DB04325 | |
| 0.012 | 0.437 | 0.037 | Somatostatin 4 agonist | 0.037 0.026 DB04325 | DB04325 | |
| 0.065 | 0.494 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.138 0.047 DBMET01954 | DBMET01954 | |
| 0.023 | 0.455 | 0.249 | Thrombolytic | 0.249 0.034 DB09269 0.164 0.072 DB04325 0.233 0.038 DBMET01954 | DB09269 | |
| 0.044 | 0.48 | 0.139 | Folate antagonist | 0.139 0.027 DB09269 0.112 0.046 DBMET01954 | DB09269 | |
| 0.011 | 0.45 | 0.081 | Lipase inhibitor | 0.081 0.042 DBMET01954 | DBMET01954 | |
| 0.014 | 0.457 | 0.116 | Adrenaline antagonist | 0.116 0.045 DB04325 | DB04325 | |
| 0.011 | 0.455 | 0.251 | 5-Lipoxygenase inhibitor | 0.183 0.028 DB09269 0.251 0.015 DBMET01954 | DBMET01954 | |
| 0.011 | 0.457 | 0.168 | CXC chemokine 4 receptor antagonist | 0.168 0.013 DB04325 | DB04325 | |
| 0.03 | 0.477 | 0.158 | Vanilloid agonist | 0.132 0.014 DB09269 0.089 0.049 DB04325 0.158 0.01 DBMET01954 | DBMET01954 | |
| 0.007 | 0.457 | 0.057 | Growth hormone secretagogue receptor antagonist | 0.057 0.015 DB04325 | DB04325 | |
| 0.007 | 0.47 | 0.066 | Phosphodiesterase 4B inhibitor | 0.066 0.048 DB09269 | DB09269 | |
| 0.051 | 0.516 | 0.222 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.222 0.076 DB04325 | DB04325 | |
| 0.018 | 0.483 | 0.05 | Factor III inhibitor | 0.05 0.034 DBMET01954 | DBMET01954 | |
| 0.004 | 0.469 | 0.033 | Factor X inhibitor | 0.033 0.032 DB04325 | DB04325 | |
| 0.006 | 0.475 | 0.211 | 5 Hydroxytryptamine 1F antagonist | 0.211 0.009 DB04325 | DB04325 | |
| 0.026 | 0.502 | 0.173 | Nav1.4 sodium channel blocker | 0.159 0.03 DB09269 0.145 0.036 DB04325 0.173 0.026 DBMET01954 | DBMET01954 | |
| 0.005 | 0.481 | 0.385 | Peroxisome proliferator-activated receptor gamma agonist | 0.385 0.004 DB09269 0.295 0.005 DBMET01954 | DB09269 | |
| 0.004 | 0.484 | 0.069 | Leukotriene D4 antagonist | 0.069 0.008 DB09269 0.05 0.01 DBMET01954 | DB09269 | |
| 0.005 | 0.485 | 0.018 | Somatostatin 3 antagonist | 0.018 0.016 DB04325 | DB04325 | |
| 0.005 | 0.489 | 0.042 | Catechol O-methyltransferase inhibitor | 0.042 0.013 DBMET01954 | DBMET01954 | |
| 0.011 | 0.496 | 0.035 | Elastase 3B inhibitor | 0.035 0.013 DB09269 0.031 0.021 DBMET01954 | DB09269 | |
| 0.011 | 0.496 | 0.035 | Elastase 3A inhibitor | 0.035 0.013 DB09269 0.031 0.021 DBMET01954 | DB09269 | |
| 0.011 | 0.496 | 0.035 | Elastase 2B inhibitor | 0.035 0.013 DB09269 0.031 0.021 DBMET01954 | DB09269 | |
| 0.005 | 0.491 | 0.119 | Urokinase inhibitor | 0.119 0.012 DB04325 | DB04325 | |
| 0.008 | 0.494 | 0.08 | p53 inhibitor | 0.08 0.004 DB09269 0.063 0.008 DBMET01954 | DB09269 | |
| 0.009 | 0.497 | 0.046 | Estrogen-related receptor beta antagonist | 0.034 0.018 DBMET01955 0.046 0.007 DBMET01954 | DBMET01954 | |
| 0.003 | 0.492 | 0.163 | Integrin alpha4 antagonist | 0.163 0.004 DB09269 0.096 0.006 DBMET01954 | DB09269 | |
| 0.006 | 0.495 | 0.14 | 5 Hydroxytryptamine 7 antagonist | 0.14 0.019 DB04325 | DB04325 | |
| 0.03 | 0.52 | 0.242 | Antiamyloidogenic | 0.177 0.117 DB09269 0.164 0.129 DB04325 0.242 0.075 DBMET01954 | DBMET01954 | |
| 0.004 | 0.499 | 0.111 | Vitronectin receptor antagonist | 0.111 0.004 DB09269 0.04 0.008 DBMET01954 | DB09269 | |
| 0.013 | 0.51 | 0.096 | Protein kinase C delta inhibitor | 0.096 0.056 DB04325 | DB04325 | |
| 0.004 | 0.502 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DB09269 | DB09269 | |
| 0.004 | 0.505 | 0.058 | Dopamine D2 agonist | 0.058 0.022 DB04325 | DB04325 | |
| 0.016 | 0.521 | 0.048 | Integrin alpha1beta1 antagonist | 0.048 0.009 DB09269 0.037 0.03 DBMET01954 | DB09269 | |
| 0.011 | 0.518 | 0.104 | Protein kinase B beta inhibitor | 0.104 0.023 DB04325 | DB04325 | |
| 0.033 | 0.544 | 0.179 | Antipruritic | 0.159 0.085 DB09269 0.179 0.065 DB04325 0.154 0.09 DBMET01954 | DB04325 | |
| 0.005 | 0.516 | 0.106 | Macrophage elastase inhibitor | 0.106 0.009 DB09269 0.068 0.015 DBMET01954 | DB09269 | |
| 0.004 | 0.518 | 0.103 | 5 Hydroxytryptamine 2C agonist | 0.103 0.007 DB04325 | DB04325 | |
| 0.032 | 0.548 | 0.175 | P-glycoprotein inhibitor | 0.17 0.09 DB09269 0.175 0.084 DBMET01954 | DBMET01954 | |
| 0.08 | 0.599 | 0.301 | Peptidyltransferase inhibitor | 0.243 0.056 DB09269 0.301 0.024 DB04325 0.257 0.046 DBMET01954 | DB04325 | |
| 0.017 | 0.538 | 0.245 | Lipid peroxidase inhibitor | 0.127 0.087 DB09269 0.119 0.094 DBMET01955 0.245 0.028 DBMET01954 | DBMET01954 | |
| 0.003 | 0.525 | 0.032 | Prostaglandin EP1 antagonist | 0.032 0.009 DB09269 | DB09269 | |
| 0.053 | 0.581 | 0.255 | Lipocortins synthesis antagonist | 0.255 0.032 DB09269 0.219 0.045 DBMET01954 | DB09269 | |
| 0.004 | 0.534 | 0.032 | Integrin alphaVbeta1 antagonist | 0.032 0.005 DB09269 0.024 0.009 DBMET01954 | DB09269 | |
| 0.004 | 0.535 | 0.025 | Dopamine D1 agonist | 0.025 0.013 DB04325 | DB04325 | |
| 0.006 | 0.538 | 0.063 | Integrin alpha5beta1 antagonist | 0.063 0.01 DB09269 0.049 0.019 DBMET01954 | DB09269 | |
| 0.026 | 0.559 | 0.217 | Amyloid beta aggregation inhibitor | 0.217 0.069 DBMET01954 | DBMET01954 | |
| 0.003 | 0.549 | 0.052 | Sphingosine 1-phosphate receptor 3 agonist | 0.052 0.015 DB09269 0.04 0.021 DBMET01954 | DB09269 | |
| 0.013 | 0.559 | 0.344 | Cyclooxygenase 1 inhibitor | 0.333 0.011 DB09269 0.344 0.01 DBMET01954 | DBMET01954 | |
| 0.031 | 0.579 | 0.345 | Cardiotonic | 0.17 0.152 DB09269 0.345 0.04 DB04325 | DB04325 | |
| 0.012 | 0.56 | 0.111 | Prostaglandin F2 alpha antagonist | 0.111 0.008 DB09269 0.099 0.012 DBMET01954 | DB09269 | |
| 0.004 | 0.558 | 0.04 | Protease activated receptor 1 antagonist | 0.04 0.037 DB04325 | DB04325 | |
| 0.018 | 0.574 | 0.091 | Opioid kappa receptor antagonist | 0.087 0.049 DB04325 0.091 0.045 DBMET01954 | DBMET01954 | |
| 0.01 | 0.567 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 DBMET01954 | DBMET01954 | |
| 0.005 | 0.562 | 0.11 | Liver X receptor alpha antagonist | 0.11 0.004 DB09269 0.096 0.004 DBMET01954 | DB09269 | |
| 0.014 | 0.573 | 0.173 | Protein kinase (CK1) gamma 3 inhibitor | 0.173 0.066 DB04325 | DB04325 | |
| 0.003 | 0.562 | 0.021 | Kainate receptor 5 antagonist | 0.021 0.014 DB09269 | DB09269 | |
| 0.005 | 0.566 | 0.568 | 5 Hydroxytryptamine agonist | 0.568 0.004 DB04325 | DB04325 | |
| 0.011 | 0.573 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.028 DB04325 | DB04325 | |
| 0.009 | 0.573 | 0.163 | Glutamate receptor antagonist | 0.136 0.061 DB09269 0.163 0.043 DB04325 0.127 0.067 DBMET01954 | DB04325 | |
| 0.006 | 0.57 | 0.059 | Dopamine transporter inhibitor | 0.059 0.025 DB04325 | DB04325 | |
| 0.099 | 0.664 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.146 DB04325 | DB04325 | |
| 0.003 | 0.569 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.01 DB09269 | DB09269 | |
| 0.005 | 0.573 | 0.044 | Factor VIIa inhibitor | 0.044 0.022 DB04325 | DB04325 | |
| 0.002 | 0.571 | 0.109 | Estrogen receptor beta agonist | 0.109 0.01 DBMET01954 | DBMET01954 | |
| 0.008 | 0.578 | 0.203 | Sphingosine 1-phosphate receptor 5 agonist | 0.203 0.004 DB09269 0.126 0.005 DBMET01954 | DB09269 | |
| 0.03 | 0.6 | 0.078 | T cell inhibitor | 0.078 0.075 DB09269 | DB09269 | |
| 0.02 | 0.592 | 0.083 | Antineoplastic alkaloid | 0.083 0.062 DBMET01954 | DBMET01954 | |
| 0.005 | 0.579 | 0.116 | Liver X receptor antagonist | 0.116 0.005 DB09269 0.098 0.005 DBMET01954 | DB09269 | |
| 0.011 | 0.589 | 0.105 | Sirtuin 1 inhibitor | 0.105 0.02 DB04325 | DB04325 | |
| 0.004 | 0.583 | 0.299 | Aldose reductase inhibitor | 0.298 0.004 DB09269 0.299 0.004 DBMET01954 | DBMET01954 | |
| 0.008 | 0.587 | 0.135 | HIV-1 integrase inhibitor | 0.106 0.022 DB09269 0.135 0.011 DBMET01954 | DBMET01954 | |
| 0.011 | 0.593 | 0.21 | Cyclooxygenase 2 inhibitor | 0.21 0.028 DB09269 0.198 0.031 DBMET01954 | DB09269 | |
| 0.007 | 0.604 | 0.046 | Kallikrein inhibitor | 0.046 0.034 DB04325 | DB04325 | |
| 0.007 | 0.605 | 0.084 | CDC25B inhibitor | 0.071 0.037 DB09269 0.084 0.025 DBMET01954 | DBMET01954 | |
| 0.03 | 0.631 | 0.095 | Hematopoietic | 0.095 0.041 DB09269 0.092 0.045 DB04325 0.088 0.054 DBMET01954 | DB09269 | |
| 0.005 | 0.608 | 0.05 | Somatostatin agonist | 0.05 0.013 DB04325 | DB04325 | |
| 0.004 | 0.607 | 0.052 | Histamine H3 receptor agonist | 0.052 0.01 DB04325 | DB04325 | |
| 0.004 | 0.611 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DB09269 0.027 0.019 DBMET01954 | DB09269 | |
| 0.018 | 0.626 | 0.099 | Thioredoxin inhibitor | 0.082 0.077 DB09269 0.099 0.049 DBMET01954 | DBMET01954 | |
| 0.005 | 0.615 | 0.059 | 5 Hydroxytryptamine uptake inhibitor | 0.059 0.047 DB04325 | DB04325 | |
| 0.022 | 0.632 | 0.094 | Nav1.1 sodium channel blocker | 0.094 0.073 DB04325 | DB04325 | |
| 0.008 | 0.62 | 0.189 | M17 leucyl aminopeptidase inhibitor | 0.189 0.037 DB09269 0.168 0.045 DBMET01954 | DB09269 | |
| 0.004 | 0.616 | 0.047 | Protocollagen prolyl hydroxylase inhibitor | 0.046 0.006 DB09269 0.047 0.005 DBMET01954 | DBMET01954 | |
| 0.004 | 0.617 | 0.02 | Retinoic acid beta receptor agonist | 0.02 0.014 DB09269 | DB09269 | |
| 0.006 | 0.623 | 0.073 | Adrenaline uptake inhibitor | 0.073 0.032 DB04325 | DB04325 | |
| 0.007 | 0.625 | 0.069 | Protein kinase B alpha inhibitor | 0.069 0.048 DB04325 | DB04325 | |
| 0.026 | 0.653 | 0.338 | ABCA1 expression enhancer | 0.338 0.005 DB09269 0.262 0.005 DBMET01954 | DB09269 | |
| 0.011 | 0.639 | 0.056 | Glucose-6-phosphate translocase inhibitor | 0.056 0.029 DBMET01954 | DBMET01954 | |
| 0.004 | 0.642 | 0.333 | Integrin antagonist | 0.333 0.005 DB09269 0.163 0.009 DBMET01954 | DB09269 | |
| 0.01 | 0.649 | 0.177 | Carnitine palmitoyltransferase 1B inhibitor | 0.177 0.003 DB09269 0.13 0.004 DBMET01954 | DB09269 | |
| 0.03 | 0.672 | 0.13 | Interleukin 12 antagonist | 0.099 0.055 DB09269 0.13 0.021 DBMET01954 | DBMET01954 | |
| 0.01 | 0.66 | 0.042 | GHS receptor agonist | 0.042 0.031 DB04325 | DB04325 | |
| 0.012 | 0.664 | 0.062 | I kappa B kinase 1 inhibitor | 0.062 0.061 DB04325 | DB04325 | |
| 0.007 | 0.663 | 0.05 | VCAM antagonist | 0.05 0.009 DB09269 0.047 0.012 DBMET01954 | DB09269 | |
| 0.007 | 0.664 | 0.05 | VCAM-1 antagonist | 0.05 0.009 DB09269 0.047 0.012 DBMET01954 | DB09269 | |
| 0.003 | 0.672 | 0.047 | Somatostatin 5 antagonist | 0.047 0.014 DB04325 | DB04325 | |
| 0.003 | 0.676 | 0.801 | Prostaglandin D2 antagonist | 0.801 0.002 DB09269 0.54 0.003 DBMET01954 | DB09269 | |
| 0.01 | 0.688 | 0.31 | Cyclooxygenase inhibitor | 0.31 0.016 DB09269 0.297 0.018 DBMET01954 | DB09269 | |
| 0.019 | 0.697 | 0.209 | Histone deacetylase SIRT1 inhibitor | 0.209 0.027 DB04325 0.116 0.096 DBMET01954 | DB04325 | |
| 0.012 | 0.692 | 0.115 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 DB09269 0.115 0.055 DBMET01954 | DBMET01954 | |
| 0.003 | 0.687 | 0.151 | Estrogen agonist | 0.151 0.011 DBMET01954 | DBMET01954 | |
| 0.007 | 0.692 | 0.283 | Protein-tyrosine phosphatase inhibitor | 0.264 0.027 DB09269 0.283 0.022 DBMET01954 | DBMET01954 | |
| 0.018 | 0.708 | 0.082 | Caspase 9 inhibitor | 0.082 0.022 DB09269 0.067 0.035 DBMET01954 | DB09269 | |
| 0.015 | 0.712 | 0.045 | Parathyroid hormone antagonist | 0.045 0.033 DB04325 | DB04325 | |
| 0.008 | 0.714 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 DBMET01954 | DBMET01954 | |
| 0.002 | 0.711 | 0.019 | Retinoic acid alpha receptor antagonist | 0.019 0.016 DB09269 | DB09269 | |
| 0.003 | 0.712 | 0.061 | Prostaglandin D2 agonist | 0.061 0.005 DB09269 0.052 0.007 DBMET01954 | DB09269 | |
| 0.008 | 0.722 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DB09269 | DB09269 | |
| 0.004 | 0.721 | 0.034 | AMPA receptor agonist | 0.034 0.026 DB09269 | DB09269 | |
| 0.004 | 0.724 | 0.107 | Histone deacetylase SIRT2 inhibitor | 0.107 0.024 DB04325 | DB04325 | |
| 0.028 | 0.747 | 0.231 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.231 0.124 DB04325 | DB04325 | |
| 0.004 | 0.726 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DB09269 0.021 0.02 DBMET01954 | DB09269 | |
| 0.016 | 0.738 | 0.069 | Adenine nucleotide translocase inhibitor | 0.058 0.032 DB09269 0.069 0.016 DBMET01954 | DBMET01954 | |
| 0.021 | 0.743 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 DBMET01954 | DBMET01954 | |
| 0.004 | 0.726 | 0.112 | AMPA 2 receptor antagonist | 0.112 0.005 DB09269 0.066 0.008 DBMET01954 | DB09269 | |
| 0.002 | 0.732 | 0.021 | Prostacyclin agonist | 0.021 0.008 DB09269 0.015 0.012 DBMET01954 | DB09269 | |
| 0.002 | 0.733 | 0.142 | Free fatty acid receptor 1 agonist | 0.142 0.004 DB09269 0.077 0.004 DBMET01954 | DB09269 | |
| 0.006 | 0.739 | 0.075 | Plasminogen activator inhibitor | 0.054 0.044 DB09269 0.075 0.029 DB04325 | DB04325 | |
| 0.003 | 0.736 | 0.047 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.047 0.017 DBMET01954 | DBMET01954 | |
| 0.005 | 0.738 | 0.082 | Protein kinase C epsilon inhibitor | 0.082 0.018 DB04325 | DB04325 | |
| 0.009 | 0.747 | 0.065 | Autotaxin inhibitor | 0.065 0.025 DB09269 0.048 0.044 DBMET01954 | DB09269 | |
| 0.003 | 0.751 | 0.084 | Prostaglandin EP3 antagonist | 0.084 0.007 DB09269 0.043 0.012 DBMET01954 | DB09269 | |
| 0.008 | 0.756 | 0.117 | Protein kinase (CK1) gamma 1 inhibitor | 0.117 0.101 DB04325 | DB04325 | |
| 0.011 | 0.771 | 0.305 | Angiogenesis stimulant | 0.262 0.065 DB09269 0.187 0.101 DB04325 0.305 0.047 DBMET01954 | DBMET01954 | |
| 0.005 | 0.768 | 0.212 | Estrogen receptor beta antagonist | 0.122 0.03 DBMET01955 0.212 0.009 DBMET01954 | DBMET01954 | |
| 0.016 | 0.78 | 0.145 | Toll-Like receptor 4 antagonist | 0.121 0.042 DB09269 0.098 0.072 DB04325 0.145 0.024 DBMET01954 | DBMET01954 | |
| 0.007 | 0.771 | 0.22 | Anticoagulant | 0.22 0.046 DB09269 0.205 0.051 DB04325 0.158 0.073 DBMET01954 | DB09269 | |
| 0.004 | 0.768 | 0.834 | Prostaglandin antagonist | 0.834 0.003 DB09269 0.644 0.003 DBMET01954 | DB09269 | |
| 0.004 | 0.773 | 0.095 | Prostaglandin E2 antagonist | 0.095 0.016 DB09269 0.049 0.037 DBMET01954 | DB09269 | |
| 0.01 | 0.781 | 0.238 | Nitric oxide antagonist | 0.161 0.087 DB09269 0.238 0.055 DBMET01954 | DBMET01954 | |
| 0.008 | 0.781 | 0.16 | Histone deacetylase class III inhibitor | 0.16 0.037 DB04325 | DB04325 | |
| 0.005 | 0.778 | 0.138 | CDC25A inhibitor | 0.129 0.017 DB09269 0.138 0.015 DBMET01954 | DBMET01954 | |
| 0.005 | 0.781 | 0.044 | Retinoic acid alpha receptor agonist | 0.044 0.02 DB09269 0.038 0.03 DBMET01954 | DB09269 | |
| 0.003 | 0.779 | 0.032 | Endothelin receptor antagonist | 0.032 0.016 DB09269 | DB09269 | |
| 0.003 | 0.795 | 0.197 | Kinesin-like protein 1 inhibitor | 0.197 0.004 DB04325 | DB04325 | |
| 0.003 | 0.795 | 0.197 | Kinesin antagonist | 0.197 0.004 DB04325 | DB04325 | |
| 0.012 | 0.807 | 0.23 | Farnesoid X receptor antagonist | 0.176 0.031 DB09269 0.23 0.015 DBMET01954 | DBMET01954 | |
| 0.004 | 0.805 | 0.101 | Liver X receptor agonist | 0.101 0.007 DB09269 0.081 0.01 DBMET01954 | DB09269 | |
| 0.021 | 0.832 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 DBMET01954 | DBMET01954 | |
| 0.004 | 0.817 | 0.223 | Protein-tyrosine phosphatase 1B inhibitor | 0.2 0.029 DB09269 0.223 0.023 DBMET01954 | DBMET01954 | |
| 0.004 | 0.822 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 DB09269 0.074 0.039 DBMET01954 | DB09269 | |
| 0.005 | 0.832 | 0.605 | Platelet antagonist | 0.605 0.006 DB09269 0.199 0.101 DB04325 0.508 0.013 DBMET01954 | DB09269 | |
| 0.017 | 0.848 | 0.323 | Interleukin 4 antagonist | 0.241 0.014 DB09269 0.323 0.007 DBMET01954 | DBMET01954 | |
| 0.005 | 0.843 | 0.243 | Estrogen antagonist | 0.13 0.039 DBMET01955 0.243 0.009 DBMET01954 | DBMET01954 | |
| 0.013 | 0.855 | 0.359 | Immunosuppressant | 0.359 0.082 DB09269 0.215 0.181 DB04325 0.349 0.087 DBMET01954 | DB09269 | |
| 0.024 | 0.872 | 0.266 | Caspase 3 stimulant | 0.266 0.099 DBMET01954 | DBMET01954 | |
| 0.008 | 0.866 | 0.27 | Bone formation stimulant | 0.242 0.026 DB09269 0.27 0.021 DBMET01954 | DBMET01954 | |
| 0.004 | 0.871 | 0.082 | Pim-1 kinase inhibitor | 0.082 0.078 DB04325 | DB04325 | |
| 0.004 | 0.877 | 0.066 | CXC chemokine receptor antagonist | 0.066 0.055 DB04325 | DB04325 | |
| 0.005 | 0.878 | 0.298 | Cell adhesion molecule inhibitor | 0.298 0.005 DB09269 0.164 0.013 DBMET01954 | DB09269 | |
| 0.008 | 0.887 | 0.451 | Insulin secretagoues | 0.451 0.005 DB09269 0.367 0.007 DBMET01954 | DB09269 | |
| 0.008 | 0.888 | 0.142 | Interleukin 1 antagonist | 0.142 0.063 DB09269 0.135 0.07 DBMET01954 | DB09269 | |
| 0.008 | 0.892 | 0.069 | CXC chemokine 1 receptor antagonist | 0.056 0.027 DB09269 0.069 0.013 DBMET01954 | DBMET01954 | |
| 0.005 | 0.9 | 0.465 | Hypolipemic | 0.465 0.016 DB09269 0.424 0.021 DBMET01954 | DB09269 | |
| 0.003 | 0.904 | 0.229 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.229 0.004 DB09269 0.107 0.005 DBMET01954 | DB09269 | |
| 0.002 | 0.905 | 0.038 | HMG CoA reductase inhibitor | 0.038 0.017 DB09269 0.034 0.025 DBMET01954 | DB09269 | |
| 0.014 | 0.919 | 0.243 | Hepatoprotectant | 0.204 0.063 DB09269 0.243 0.045 DBMET01954 | DBMET01954 | |
| 0.005 | 0.929 | 0.398 | Cell adhesion inhibitor | 0.398 0.005 DB09269 0.273 0.012 DBMET01954 | DB09269 | |
| 0.005 | 0.935 | 0.452 | Interleukin antagonist | 0.404 0.03 DB09269 0.257 0.059 DB04325 0.452 0.024 DBMET01954 | DBMET01954 | |
| 0.019 | 0.952 | 0.205 | NOS3 expression enhancer | 0.122 0.112 DB09269 0.205 0.039 DBMET01954 | DBMET01954 | |
| 0.008 | 0.943 | 0.144 | Interleukin 1b antagonist | 0.144 0.045 DB09269 0.114 0.067 DBMET01954 | DB09269 | |
| 0.003 | 0.939 | 0.12 | Phosphodiesterase 4D inhibitor | 0.12 0.028 DB09269 0.111 0.032 DBMET01954 | DB09269 | |
| 0.01 | 0.955 | 0.135 | Interleukin 5 antagonist | 0.131 0.017 DB09269 0.135 0.016 DBMET01954 | DBMET01954 | |
| 0.005 | 0.951 | 0.361 | Platelet aggregation inhibitor | 0.361 0.024 DB09269 0.241 0.056 DBMET01954 | DB09269 | |
| 0.01 | 0.959 | 0.353 | Apoptosis antagonist | 0.32 0.073 DB09269 0.197 0.183 DB04325 0.353 0.055 DBMET01954 | DBMET01954 | |
| 0.005 | 0.962 | 0.633 | Toll-Like receptor 7 agonist | 0.633 0.014 DB09269 0.546 0.024 DBMET01954 | DB09269 | |
| 0.006 | 0.965 | 0.239 | Interleukin 6 antagonist | 0.239 0.025 DB09269 0.237 0.026 DBMET01954 | DB09269 | |
| 0.005 | 0.964 | 0.63 | Toll-Like receptor agonist | 0.63 0.014 DB09269 0.54 0.025 DBMET01954 | DB09269 | |
| 0.005 | 0.97 | 0.229 | Analgesic | 0.227 0.206 DB09269 0.229 0.204 DBMET01954 | DBMET01954 | |
| 0.005 | 0.97 | 0.416 | Antiobesity | 0.416 0.06 DB09269 0.31 0.11 DBMET01954 | DB09269 | |
| 0.005 | 0.973 | 0.302 | Apoptosis agonist | 0.302 0.171 DBMET01954 | DBMET01954 | |
| 0.004 | 0.992 | 0.27 | Immunomodulator | 0.27 0.1 DB09269 0.205 0.158 DBMET01954 | DB09269 | |
| 0.004 | 0.995 | 0.595 | Antiinflammatory | 0.578 0.06 DB09269 0.595 0.055 DBMET01954 | DBMET01954 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |